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Articular cartilage functions to maintain joint mobility.  The loss of healthy, 
functional articular cartilage due to osteoarthritis or injury can severely compromise 
quality of life.  To address this issue, cartilage tissue engineering approaches are 
currently in development.  Bone marrow-derived mesenchymal progenitor cells (MPCs) 
hold much promise as an alternative cell source for cartilage tissue engineering and other 
cell-based cartilage repair approaches.  While previous studies have established that 
MPCs from humans and a number of other species undergo in vitro chondrogenic 
differentiation, additional research is needed to define conditions that will enhance 
chondrogenic differentiation of MPCs, increase matrix production by differentiating 
cultures, and further support development of functional tissue-engineered cartilage 
constructs.  Mechanical loading may be an important factor regulating chondrogenic 
differentiation of MPCs and cartilage matrix formation by chondrogenic MPCs.  This 
thesis work evaluated the influence of oscillatory unconfined compressive mechanical 
loading on in vitro MPC chondrogenic activity and biosynthesis within hydrogel 
suspension.   
Loading was conducted using MPCs cultured in media supplements supporting 
chondrogenic differentiation, thereby enabling the evaluation of distinct MPC cultures 
based upon the time of loading initiation.  Possible interactions between the number of 
days in chondrogenic media preceding loading initiation and the ability of the MPC 
culture to respond to mechanical stimulation were explored in two different loading 
studies.  The first loading study investigated the effects of 3 hour periods of daily 
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oscillatory mechanical stimulation on subsequent chondrogenic activity, where 
chondrogenic activity represented an assessment of cartilage matrix production by 
differentiating MPCs focusing on proteoglycan synthesis and sGAG accumulation.  This 
study found that oscillatory compression of MPCs initiated during the first seven days of 
culture did not enhance chondrogenic activity above the level supported by media 
supplements alone.  The second loading study evaluated changes in biosynthesis during a 
single 20 hour period of oscillatory mechanical stimulation to assess 
mechanoresponsiveness of the MPC cultures.  This study found that MPCs modulated 
proteoglycan and protein synthesis in a culture time-dependent and frequency-dependent 
manner upon application of oscillatory compression.  Together the two loading studies 
provide an assessment of dynamic compressive mechanical loading influences on MPC 
cultures undergoing chondrogenic differentiation.  The information gained through in 
vitro studies of differentiating MPC cultures will increase basic knowledge about 
progenitor cells and may also prove valuable in guiding the future development of 








Articular cartilage functions to maintain joint mobility by providing a low friction 
interface under complex cyclic mechanical loading.  The loss of healthy, functional 
articular cartilage due to osteoarthritis or injury results in joint pain and loss of mobility, 
severely compromising quality of life.  Due to its avascularity and relative acellularity, 
cartilage has a limited capacity for self-repair, both in response to acute injuries and 
chronic degeneration [1, 2].  Although limited progress has been made, current clinical 
solutions to repair cartilage damage fail to restore long-term function and alternative 
cartilage repair strategies are needed.   
Tissue engineering approaches for articular cartilage repair are currently in 
development, with the goal to restore tissue functionality in the damaged regions [3, 4].  
These approaches generally involve culturing chondrocytes on three-dimensional (3-D) 
scaffold materials in vitro to produce a cartilage-like tissue that can then be implanted 
into the defect site [5-8].  While the use of tissue-engineered cartilage holds much 
promise as a future clinical strategy, the development of this technology is hindered in 
part by the lack of a sufficient donor cell population.  Articular chondrocytes can be 
isolated from mature tissue, but problems associated with this approach include limited 
tissue harvest sites, tissue donor site morbidity, and limited expansion potential of the 
donor population [6, 9].   
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More recently, mesenchymal progenitor cell populations (MPCs) from tissues 
including periosteum, bone marrow, and adipose tissue have been shown to contain cells 
capable of chondrogenic differentiation when exposed to appropriate growth factor 
stimulation [10-14].  The use of progenitor cells in cartilage tissue engineering may avoid 
the problems associated with use of mature chondrocytes.  Progenitor cells can be more 
easily harvested, are isolated from tissue that can be replenished or replaced, and have a 
higher proliferative potential [1].  However, optimal conditions that will enhance 
chondrogenic differentiation of MPCs, increase matrix production by differentiating 
cultures, and support development of functional tissue-engineered cartilage constructs 
have not been defined.   
Mechanical loading has been proposed as a stimulatory factor for the in vitro 
development of tissue-engineered cartilage constructs [15-17].  Mechanical loading may 
be an important factor regulating chondrogenic differentiation of postnatal progenitor 
cells and cartilage matrix formation by maturing chondroprogenitor cells.  The 
biomechanical environment has been proposed to play a fundamental role in the 
development and maturation of cartilage [18].  Developmental biology studies support 
the idea that the biomechanical environment helps guide cartilage formation from the 
undifferentiated mesenchyme during limb and joint development [19, 20].  Thus, 
consideration of mechanical loading effects on MPC chondrogenic differentiation, on 
matrix production by differentiating cultures, and on long-term tissue development may 
be critical to the in vitro development of tissue-engineered cartilage constructs utilizing 
MPCs.  However, studies concerning the specific effects of mechanical stimulation on 
MPCs seeded within 3-D matrices have been limited. 
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Thesis Objective  
The objective of this thesis work was to evaluate the influence of dynamic 
mechanical stimulation on in vitro chondrogenic activity and biosynthesis of 
differentiating MPCs within hydrogel suspension.  Oscillatory unconfined compressive 
mechanical loading was chosen as the loading mode of interest based in part upon the 
primary role of compression in normal repetitive joint loading [21, 22].  Compressive 
mechanical loading has also been evaluated in previous in vitro loading studies with 
cartilage explants, isolated chondrocytes, and chondroprogenitor populations [19, 23, 24].  
To focus on mechanical stimulation of differentiating MPC cultures, loading was 
conducted using MPCs exposed to media supplements which supported chondrogenic 
differentiation and loading was initiated during the first week of culture.  Altering the 
culture time for loading initiation enabled comparisons of loading effects on distinct 
MPC cultures.  In evaluating loading effects on MPC chondrogenic activity, this activity 
represented an assessment of cartilage matrix production by differentiating MPCs 
focused on proteoglycan synthesis and sGAG accumulation. 
Specific Aims 
Three specific aims were set forth to address the thesis objective.  Guiding the 
development of these aims was the underlying primary focus of the thesis work, which 
was to explore possible interactions between the length of culture time (i.e. number of 
days) in chondrogenic media preceding loading initiation and the ability of the MPC 
culture to respond to mechanical stimulation.  The length of culture time preceding 
loading initiation would be representative of both cellular changes related to the current 
differentiation “state” of the cell and extracellular changes resulting from matrix 
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production by the differentiating MPCs.  After defining appropriate conditions for MPC 
chondrogenic differentiation in Aim 1, Aim 2 investigated the effects of 3 hour periods of 
daily oscillatory mechanical stimulation on MPC chondrogenic activity.  Finally, Aim 3 
evaluated changes in biosynthesis during a single 20 hour period of oscillatory 
mechanical stimulation to assess mechanoresponsiveness of the MPC cultures.   
Specific Aim 1: To define culture media conditions that support goat MPC chondrogenic 
differentiation and subsequent matrix accumulation in hydrogel suspension and to 
establish a time course for matrix synthesis and accumulation 
Although basic chondrogenic media conditions supporting MPC differentiation and 
matrix accumulation had been previously established, species variability had been noted 
and a comprehensive evaluation of the effects of specific media components was lacking 
in the literature.  Furthermore, cartilage matrix production by goat MPCs undergoing 
chondrogenic differentiation had been evaluated only at one or two selected times in 
previous studies.  Therefore, experiments were conducted to evaluate media conditions 
and to assess the timing of matrix synthesis and accumulation in preparation for the 
loading studies.  
The evaluation of chondrogenic differentiation utilized biochemical analyses and 
histological analyses to validate the production of the two major structural components of 
articular cartilage: proteoglycans and type II collagen.  Proteoglycan production was 
assessed quantitatively by determining proteoglycan synthesis, measured as the 35S-
sulfate incorporation rate, and sulfated glycosaminoglycan (sGAG) accumulation.  Type 
II collagen production was assessed qualitatively with immunohistochemical staining.  
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Protein synthesis, measured as the 3H-proline incorporation rate, and DNA content were 
also evaluated as general culture markers.   
The initial culture conditions utilized TGF-β1 and/or dexamethasone, 
supplementation factors used previously in human MPC differentiation studies, to 
evaluate effects on chondrogenic differentiation and matrix accumulation [11, 12, 25].  
The duration over which supplementation factors were provided (early versus entire 
culture period) was also evaluated.  Criteria for comparison of culture media conditions 
included the ability to support production of cartilage matrix components and the amount 
of matrix accumulation.   
Specific Aim 2: To evaluate the effects of oscillatory compressive loading on MPC 
chondrogenic activity  
The effects of oscillatory mechanical stimulation on differentiating MPC cultures 
were evaluated by assessing the chondrogenic activity following application of daily 3 
hour loading periods for 3 consecutive days.  Since the duration of exposure to 
chondrogenic media preceding loading initiation could modulate the MPC response to 
mechanical loading, oscillatory unconfined compressive loading was initiated following a 
variable preculture period of 1 to 21 days in media containing TGF-β1, a supplement 
demonstrated to support MPC chondrogenic differentiation.  It was hypothesized that 
dynamic compressive loading in combination with chondrogenic supplements would 
enhance the chondrogenic activity of MPCs relative to the influence of supplements alone 
in a preculture time-dependent manner.  Proteoglycan synthesis, measured as the 35S-
sulfate incorporation rate, and proteoglycan accumulation, measured as sulfated 
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glycosaminoglycan (sGAG) accumulation, were utilized to assess MPC chondrogenic 
activity and were supported by the detection of type II collagen expression.   
Specific Aim 3: To evaluate MPC biosynthesis during continuous oscillatory 
compressive loading 
The mechanoresponsiveness of MPC/alginate cultures undergoing chondrogenic 
differentiation was evaluated for a loading protocol shown previously to enhance 
biosynthesis of chondrocytes in hydrogel suspension [24].  Our hypothesis was that 
oscillatory compressive mechanical loading would stimulate proteoglycan and protein 
synthesis in differentiating MPC cultures, but would not modulate biosynthesis in 
prechondrogenic MPC cultures.  Oscillatory compressive loading was applied 
continuously for a single 20 hour period to gels that were being cultured in media 
containing radiolabeled sulfate (for proteoglycan synthesis) and proline (for protein 
synthesis) compounds.  For all groups, the effects of loading were determined by 
comparing radiolabel incorporation rates in dynamically loaded constructs to static 
control constructs.  Loading was initiated at culture times (days 1, 4, and 7) demonstrated 
in Aims 1 and 2 to correspond to distinct MPC cultures, as distinguished by increasing 
levels of proteoglycan synthesis and sGAG accumulation with increasing time in culture.       
3-D MPC Culture System 
Culture of goat MPCs in alginate suspension was the standard 3-D culture system 
utilized in all thesis aims.  In selecting the MPC species for the thesis work, long-term 
directions related to this work were taken into consideration.  It was therefore decided to 
choose an adult nonhuman species that would be appropriate for use as a future in vivo 
cartilage repair model.  Selection of the goat was based in part upon the recognition that 
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this species had been used increasingly for cartilage repair studies in recent years [26-28].  
Moreover, in vitro chondrogenic differentiation of goat MPCs had been previously 
demonstrated [29, 30].   
Alginate was selected as the hydrogel to be utilized in the thesis experiments.  
Alginate is a linear polymer composed of β-D-mannuronic acid blocks, α-L-guluronic 
acid blocks, and mixed blocks linked by glycosidic bonds.  A viscous solution of alginate 
can be converted into a thermally irreversible gel by exposure to multivalent cations.  The 
cations form crosslinks in alginate by binding the guluronic residues, inducing a sol-gel 
transition in the material, and this crosslinking can be reversed by ion exchange.  The 
selection of alginate was related in part to the long-term application of this work.  The 3-
D culture system needed to be appropriate for possible future in vivo evaluations.  
Alginate has served as a matrix to deliver chondrocytes and MPCs to cartilage defects 
[31, 32].  De novo cartilage formation has been observed in chondrocyte/alginate 
constructs implanted subcutaneously in mice [33, 34].  Furthermore, alginate has 
frequently been used for in vitro culture of chondrocytes [35-37].  More recently, alginate 
hydrogels have been demonstrated to support chondrogenic differentiation of MPC 
cultures [38-40].  Importantly, alginate has also been used as a culture system for in vitro 
mechanical loading of isolated chondrocytes [41, 42].   
Significance 
Bone marrow-derived MPCs hold much promise as an alternative cell source for 
cartilage tissue engineering and other cell-based cartilage repair approaches.  The 
combination of signals present in the cartilage repair environment will influence all 
aspects of new tissue development resulting from implanted MPCs, from the early stage 
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of chondrogenic differentiation to the intermediate stage of matrix production by 
differentiating and maturing cultures to the late stage of long-term tissue growth and 
integration.  The contributions of specific factors to each of these stages cannot be 
determined within the complex in vivo environment.  In vitro studies are therefore 
necessary to rigorously evaluate the influence of isolated factors, such as mechanical 
stimuli, on MPC cultures.  The primary concern of this thesis was to evaluate the 
influence of dynamic mechanical stimulation on MPC chondrogenic activity and 
biosynthesis, thereby addressing an issue that had received only limited attention in prior 
experimentation with MPCs.  Furthermore, studies were conducted with goat MPCs, 
providing previously unknown information about a nonhuman MPC population that 
correlates to a current preclinical animal model of cartilage repair.  The studies in aims 1 
and 2 contributed to knowledge about factors influencing chondrogenic differentiation 
and subsequent matrix production by differentiating MPC cultures, while the studies in 
Aim 3 aided in further characterizing the phenotype of differentiating MPC cultures.  The 
information gained through in vitro studies of differentiating MPC cultures will be 
important for increasing basic understanding of MPCs and may also prove valuable in 
guiding the future development of cartilage repair approaches. 
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CHAPTER 2  
LITERATURE REVIEW 
 
Hyaline Cartilage: Development and Growth 
Hyaline cartilage is a tissue critical to the body’s structural framework and function.  
It serves important roles in joint mobility, as the lining for articulating bone surfaces, and 
in bone growth and repair, as the scaffold that supports bone formation in endochondral 
ossification.  Chondrocytes are the cellular mediators of cartilage genesis, growth, and 
maturation.  Chondrogenesis involves the commitment of undifferentiated mesenchymal 
cells to the chondrocyte lineage.  This process is critical to appendicular skeletal 
development and supports cartilage formation leading to endochondral ossification in 
fracture repair sites.  After chondrogenesis and subsequent cartilage formation, 
chondrocytes follow a distinct differentiation pathway determined by the cartilage type.  
In growth plate and fracture callus cartilage, chondrocytes undergo proliferation followed 
by maturation to the terminally differentiated hypertrophic phenotype.  Expression of the 
hypertrophic phenotype is critical to the progression of endochondral ossification.  In 
mature articular cartilage, chondrocytes typically maintain a resting, non-proliferative 
phenotype.  However, in pathological conditions such as osteoarthritis, articular 
chondrocytes express some characteristics of the hypertrophic phenotype.    
During embryogenesis, mesenchymal cells from the limb buds undergo a coordinated 
process of condensation and chondrogenesis leading to the formation of cartilaginous 
models of the appendicular skeletal elements [43].  The majority of embryonic limb 
cartilage is eventually degraded and replaced by bone and marrow elements in a series of 
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regulated cycles of endochondral ossification [44].  The first wave of endochondral 
ossification is initiated at the central primary ossification site in the limb and eventually 
extends toward the limb ends, leading to the appearance of the diaphyseal cavity and the 
establishment of the epiphyseal growth plates.  In early postnatal life, the appearance of 
the secondary ossification centers in the epiphyseal regions leads to the replacement of 
epiphyseal cartilage with trabecular bone, while the growth plates remain intact.  
Endochondral ossification occurs at the terminal hypertrophic zones of the growth plates, 
leading to longitudinal bone growth.  The growth plates persist throughout puberty, but 
are eventually replaced by bone in the adult.  The developmental origins of articular 
cartilage are less clear and could include contributions from epiphyseal limb 
chondrocytes and from mesenchymal interzone cells present during joint development 
[45].  Articular cartilage undergoes growth and zonal organization, leading to the 
development of a mature tissue present throughout postnatal life [46].  A region of 
calcified cartilage serves as the interface between articular cartilage and the underlying 
subchondral bone.  The calcified cartilage supports endochondral ossification, leading to 
bone deposition and remodeling at the interface [47].       
Regulation of chondrogenesis during embryonic skeletal development has been 
studied in both in vivo and in vitro models.  The onset of chondrogenesis is preceded by 
the condensation of mesenchymal cells, mediated through the interactions of cell 
adhesion molecules including N-CAM and N-cadherin [43].  Condensation leads to the 
activation of multiple transcription factors and is thought to promote a cell shape 
conducive to chondrocyte differentiation directly related to cytoskeletal rearrangement 
[48, 49].  Present in both chondroprogenitor cells and chondrocytes, Sox-9 has been 
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proposed to be a master transcription factor for chondrocyte differentiation and may 
regulate multiple steps in chondrogenesis [50].  It directly supports the expression of 
genes for the cartilage matrix proteins aggrecan and types II, IX, and XI collagen, while 
its absence has been shown to block mesenchymal condensation [51, 52].  Multiple 
factors have been demonstrated to promote in vitro chondrocyte differentiation in limb 
bud cultures and mesenchymal cell lines, including members of the TGF-β and BMP 
families [53-57].  
Articular Cartilage: Importance of Structure and the Biomechanical Environment 
Articular cartilage is the hyaline cartilage lining the contacting bone surfaces in 
joints.  It is a dense connective tissue consisting of tissue fluid, an extracellular matrix 
composed of collagens, proteoglycans, and noncollagenous proteins, and chondrocytes.  
It acts to resist compression, distribute joint forces, and provide a low-friction bearing 
surface.  The composition and structure of the cartilage tissue directly contribute to tissue 
function.  Tissue fluid comprises up to 80% of the cartilage wet weight and consists of 
water with dissolved gases, metabolites, and cations.  Water in the tissue is pressurized 
during loading and supports a significant portion of the load.  Proteoglycans are 
composed of a protein core that is associated with glycosaminoglycan chains, which are 
formed from disaccharides that contain negatively charged sulfate and carboxylate 
groups.  While proteoglycans are present in cartilage in several forms, it is the large, 
aggregating proteoglycans that notably contribute to tissue hydration and thereby 
indirectly support the tissue’s resistance to compression.  Type II collagen is the 
predominant collagen in articular cartilage and, combined with minor portions of types 
IX and XI collagen, forms a fibrillar mesh that provides the tissue with tensile strength. 
 12
The biomechanical environment plays an important role in the maturation and 
maintenance of articular cartilage.  Articular cartilage has been demonstrated to respond 
to changes in mechanical loading across the joint.  Experimental studies have indicated 
that exercise leads to increased proteoglycan content in articular cartilage, while joint 
immobilization leads to a loss of proteoglycan content that can be recovered with 
restoration of joint mobility [58].  These changes in tissue composition are the result of 
changes in chondrocyte metabolism.  In vitro studies have provided fundamental 
information regarding how mechanical loading influences articular chondrocytes.  Static 
compression of cartilage explants decreased 3H-proline and 35S-sulfate incorporation, 
while dynamic compression increased 3H-proline and 35S-sulfate incorporation within 
given frequency and deformation ranges [23, 59, 60].     
While cartilage explant culture retains many aspects of the biomechanical 
environment chondrocytes experience in vivo, the complexity of the system makes it 
challenging to discern how individual factors may influence chondrocyte behavior.  To 
further explore linkages between mechanical stimulation and changes in cellular 
activities, in vitro studies have been conducted on isolated chondrocytes.  In studies with 
chondrocytes suspended in hydrogels, the length of culture time preceding exposure to 
compressive mechanical loading appeared to influence the cellular response.  For gel 
suspensions subjected to loading after multiple weeks of culture, static compression was 
found to decrease 3H-proline and 35S-sulfate incorporation, while dynamic loading 
increased both incorporation rates [24, 41].  For gel suspensions subjected to loading 
within the first 1-5 days of culture, dynamic loading stimulated 35S-sulfate incorporation, 
but the modulation of 3H-proline incorporation by dynamic loading was found to be 
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variable [24, 61, 62].  Conversely, nitric oxide production was inhibited by oscillatory 
compression in early gel cultures [63].  Hydrostatic pressure and pressure-induced strain 
stimulated proteoglycan synthesis in chondrocyte monolayers [64, 65].  Type II collagen 
and aggrecan mRNA levels were stimulated by intermittent hydrostatic pressure, but not 
influenced by constant pressure, in monolayer cultures [66].  Type II collagen and 
aggrecan mRNA were inhibited, while nitric oxide production was stimulated by shear 
stress applied to monolayers [67].  The response of isolated chondrocytes to mechanical 
loading, in the absence of an extensive extracellular matrix, may have important 
implications for cartilage repair strategies.       
Clinical Repair Strategies for Articular Cartilage 
Maintaining the integrity of articular cartilage is crucial to normal joint mechanics, 
yet cartilage that is damaged by acute injury or chronic degeneration is unable to be 
restored by an intrinsic healing process [1, 2].  This lack of self-repair may be related in 
part to the lack of a sufficient cell population to mediate the repair process.  Cartilage has 
a low cellularity, with the chondrocyte population comprising less than 10% of the tissue 
volume, and chondrocyte proliferation and turnover in normal adult cartilage is limited.  
Moreover, chondrocytes are confined within a dense extracellular matrix, restricting 
cellular access to sites of damage. Mature articular cartilage also appears to lack a 
resident chondroprogenitor or stem cell population that could support tissue regeneration.  
Articular cartilage is an avascular tissue, thereby negating access to potential 
progenitor cell populations from other sites.  Structural damage that extends to the 
subchondral bone and causes bleeding in the damaged tissue results in the formation of a 
repair tissue.  However, the repair tissue is most frequently a type of fibrocartilage, rather 
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than hyaline cartilage, and is unable to withstand repeated mechanical loading associated 
with normal joint motion due to its inferior mechanical properties, eventually resulting in 
tissue degeneration [68].  Repair techniques including drilling and abrasion purposely 
injure the underyling subchondral bone in order to induce bleeding and ultimately support 
fibrocartilage formation [2], which in certain situations may be an acceptable clinical 
outcome.    
Clinical strategies for cartilage repair may involve the transfer of cells or tissue to the 
damaged site to promote healing.  Transplantation of autologous chondrocytes [69, 70] 
and transplantation of osteochondral grafts [71-73], either autografts or allografts, are two 
approaches that have been used for treatment of focal defects and demonstrated good 
clinical outcomes.  A pair of recent clinical reports provided direct comparisons of these 
two approaches and came to opposite conclusions regarding which was the better 
approach [74, 75].  Transplantation of soft-tissue grafts containing a chondroprogenitor 
population, such as periosteum or perichondrium, have been explored for repair of both 
focal and larger cartilage regions [76-78].  Currently for patients with extensive tissue 
loss, the primary treatment option beyond pain management strategies is total knee 
replacement surgery.   
Cartilage Tissue Engineering: Strategies for De Novo Cartilage Development  
During the last decade, much research has focused on the tissue engineering of 
articular cartilage as an alternative approach to current clinical options for cartilage 
repair.  The primary objective of the tissue engineering approach is to promote complete 
regeneration of normal articular cartilage, and if necessary, the underlying subchondral 
bone.  Guiding this objective is the belief that normal tissue function must be restored to 
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achieve long-term stability and clinical success.  A major strategy for tissue engineering 
of articular cartilage has focused on growing de novo cartilage in vitro, with the viable 
cartilage tissue subsequently used to replace a region of damaged cartilage tissue in vivo.  
De novo cartilage has been produced in vitro through the combination of an appropriate 
cell population with a 3-D scaffold followed by sustained growth in serum-containing 
media.   
The most frequently used cell source for tissue engineering approaches is the articular 
chondrocyte population.  Upon isolation from native tissue, the articular chondrocyte 
population typically must be subjected to in vitro expansion to generate sufficient cell 
numbers for scaffold seeding.  It has been demonstrated that monolayer expansion of 
articular chondrocytes can lead to dedifferentiation, or the loss of phenotype, in the 
expanded cell population, but recovery of phenotype is associated with reintroduction of 
the cells into a 3-D culture environment [37, 79, 80].  Problems associated with use of 
articular chondrocytes include: limited availability of appropriate cartilage tissue harvest 
sites, as these sites must be non-weight bearing; tissue donor site morbidity, as these 
harvest sites will not heal; increased patient cost and risk, as the tissue biopsy requires a 
surgical procedure; and limited expansion potential of the donor population [6, 9].   
More recently, mesenchymal progenitor cell populations (MPCs) from tissues 
including periosteum, bone marrow, and adipose tissue have been shown to contain cells 
capable of chondrogenic differentiation when exposed to appropriate chemical factors 
[10-14].  Progenitor cells can be more easily harvested, are isolated from tissue that can 
be replenished or replaced, and have a higher proliferative potential as compared to 
articular chondrocytes [1].  Another advantage of using a progenitor cell source is that the 
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undifferentiated cells can be guided into cellular lineages for both cartilage and bone, 
thereby enabling development of complex tissue engineering scaffolds conducive for 
repair of an osteochondral defect [81, 82].  The use of progenitor cells in cartilage tissue 
engineering will need to be supported by optimization of in vitro conditions to stimulate 
proliferation and chondrogenic differentiation of progenitor cells in appropriate scaffolds.    
The scaffold plays a central role in the development of de novo cartilage by providing 
an initial 3-D framework for cellular distribution and matrix accumulation.  The most 
extensively studied scaffold materials shown to support in vitro tissue development have 
been the biodegradable synthetic polymers PGA, PLLA, and the copolymer PLGA [8, 
83-85].  Gel-forming biomaterials have been utilized for chondrocyte encapsulation and 
have been demonstrated to support maintenance of the chondrocyte phenotype.  These 
materials include fibrillar proteins, such as type I collagen [86, 87], naturally-occurring 
polysaccharides, such as agarose and alginate [36, 88, 89], and synthetic hydrogels, 
including PEG-based and peptide-based formulations [90, 91].  However, long-term 
studies demonstrating extensive de novo cartilage growth are lacking for most of these 
materials.  A few approaches have evaluated developing de novo cartilage tissue in the 
absence of a scaffold material [92, 93], although producing a tissue of suitable 
dimensions could be a major obstacle.      
The in vitro culture environment in which chondrocyte-seeded scaffolds are grown is 
another factor that contributes to de novo tissue development.  Growth of scaffolds in a 
“static” environment, comparable to the method used for monolayer cell expansion in 
culture flasks, has been shown to produce a cartilage tissue that is lacking suitable tissue 
organization [68, 94].  Culture systems that incorporate media mixing or controlled media 
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flow, often termed bioreactors, provide several advantages over static culture including 
enhanced mass transport, a more controlled biochemical environment, and the application 
of biomechanical stimuli.  A number of bioreactors have been designed to control the 
movement of culture media through and around the cell-seeded scaffolds, including 
perfusion bioreactors [95, 96], a rotating wall bioreactor [94], and a concentric cylinder 
bioreactor [97].  Culture systems have also been developed which apply mechanical 
stimulation to the scaffolds either through application of direct compressive deformation 
or through application of hydrostatic pressurization [15, 98, 99].  Growth factor 
supplementation, such as IGF-I or TGF-β1, has been combined with mechanical 
stimulation or bioreactor culture to further enhance matrix deposition and improve 
mechanical properties of the developing tissue [100, 101].  The most successful culture 
strategies have produced de novo cartilage after 4-8 weeks of growth having a 
glycosaminoglycan composition ~75% of native tissue, having a collagen composition 
~10-40% of native tissue, and having mechanical properties ~20% of values measured in 
native tissue, with notably greater enhancement observed for selected mechanical 
parameters [102, 103].   
Bone Marrow-Derived Adult Mesenchymal Progenitor Cells 
Bone marrow contains cells of the hematopoietic lineage, in various stages of 
differentiation, and the nonhematopoietic cells that constitute the bone marrow stroma, 
including endothelial cells, adipocytes, and fibroblasts.  Early evidence for the presence 
of skeletal progenitor cells in bone marrow was provided by diffusion chamber studies, 
which demonstrated in vivo bone and cartilage formation within diffusion chambers 
containing cells from bone marrow [104].  Since the diffusion chamber system allowed 
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nutrient exchange but blocked cellular interactions with the host environment, the new 
tissue directly resulted from the implanted cells.  Subsequently, protocols for human bone 
marrow were developed to enable isolation of these progenitors, now commonly referred 
to as MPCs, based primarily on culture adherence and expansion on tissue culture plastic 
[105-107].  Similar protocols have been utilized for MPC isolation in multiple donor 
species including rat, rabbit, canine, equine, bovine, and goat [29, 106, 108-111].    
MPCs, also called mesenchymal stem cells, have been postulated to have the potential 
to give rise to cell lineages which form all mesenchymal tissues [112].  Specific chemical 
factors have been shown to promote in vitro differentiation of MPCs into lineages for 
osteoblasts, chondrocytes, adipocytes, and marrow stromal cells [11, 113-116].  There 
has been recent evidence to suggest the possible existence of multiple stem cell 
populations in the bone marrow.  A progenitor cell population, termed multipotent adult 
progenitor cells, has been isolated from bone marrow utilizing a low-serum or serum-free 
culture media combined with extensive monolayer cell expansion [117, 118].  This stem 
cell population has been shown to undergo in vitro and in vivo differentiation into cells 
from all three developmental lineages, including osteoblasts, endothelial cells, and 
neurons [119, 120].      
The estimated frequency of MPCs in marrow is 1 in 100,000 nucleated cells [114, 
121].  While the number of MPCs that can be isolated from a single marrow aspirate is 
relatively small, MPCs are capable of extensive self-renewal [122].  Thus, serial 
passaging can be used to notably expand the undifferentiated MPC population.  In 
general, the ability of MPCs to differentiate upon exposure to appropriate signals is 
retained with passaging.  Limited evidence suggests that the differentiation potential for 
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the chondrogenic lineage is sensitive to extensive passaging, but use of FGF-2 during 
monolayer expansion may help enhance this potential [123].  Aging has been shown to 
reduce the frequency of MPCs with osteogenic potential isolated from human and rodent 
donors [124-126].  Common orthopaedic diseases also appear to influence MPC 
characteristics.  Decreased osteogenic potential was noted in MPCs from osteoporotic 
patients [127, 128].  MPCs taken from patients with advanced osteoarthritis were shown 
to have a reduced proliferative capacity and reduced chondrogenic and adipogenic 
potential, although osteogenic potential was normal [129]. 
The current, standard MPC isolation protocol is fairly simplistic, relying on adherent 
culture with growth in the presence of an optimized serum lot to select the MPC 
population [130].  Clonal analyses demonstrating osteogenic, chondrogenic, and 
adipodenic differentiation of progeny from a single MPC have provided direct evidence 
for the existence of a multilineage progenitor or stem cell.  The observations in these 
studies that many clones supported only osteogenic differentiation may indicate that the 
isolated MPC population is a mixture of both stem cells and osteoprogenitors [113, 131].  
A number of protocols utilizing specific cell-surface markers coupled with various cell-
sorting techniques have recently been proposed for isolation of a better characterized 
MPC population [132-134].   
MPCs are a promising cell source for regeneration and repair of orthopaedic tissues, 
such as cartilage and bone.  In vivo osteochondrogenesis has been demonstrated for 
human, rat, and canine MPC donors [109, 135, 136].  These in vivo studies evaluated 
ectopic tissue formation in subcutaneous implants of cell-seeded ceramics or in peritoneal 
implants of cell-seeded diffusion chambers.  One such study confirmed that new bone 
 20
formation was derived from the implanted MPCs rather than from host cells using 
immunocytochemical analyses [105].  Implanted MPCs have also contributed to cartilage 
and bone repair.  Rabbit MPCs in collagen gels supported orthotopic tissue formation in 
osteochondral defects [108].  Canine MPCs seeded in ceramic carriers promoted healing 
of a segmental bone defect.  While these studies involved the implantation of 
undifferentiated MPCs, more recent work has evaluated cartilage and bone formation 
resulting from MPCs that have been subjected to a specific culture medium supporting 
predifferentiation of the MPCs toward the chondrogenic or the osteogenic lineage prior to 
implantation [81, 82].  Notably, a two-week preculture of MPCs in chondrogenic 
supplements supported enhanced bone and cartilage formation over the implantation of 
unstimulated MPCs in subcutaneous implants of a hyaluronan-gelatin composite sponge 
[137].   
Role of the Biomechanical Environment in Orthopaedic Tissue Development and Repair     
The importance of the biomechanical environment in the growth and maintenance of 
bone and cartilage is well-established [58, 138, 139].  The biomechanical environment is 
also thought to play a role in skeletal tissue development and repair, mediated in part 
through influences on lineage commitment of stem cells and progenitor cell 
differentiation.  In vivo observations have provided evidence for links between 
mechanical loading and skeletal tissue development and repair.  Paralysis of chick 
embryos leads to reduced long bone growth [140, 141], which may be due to a disruption 
in loading of appendicular skeletal elements resulting from muscular contractions [18].  
The degree of mechanical stability alters tissue development during fracture repair, 
suggesting that the local mechanical environment directly influences progenitor cell 
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differentiation at the fracture site [142, 143].  Rigid stabilization supports 
intramembranous bone formation, in which new bone forms directly from osteogenic 
differentiation of progenitor cells.  Fixation that allows moderate interfragmentary 
movement in the fracture site supports endochondral bone formation, in which bone 
formation is preceded by cartilage formation and mineralization.  During the 
endochondral process, new tissue formation involves successive waves of progenitor cell 
differentiation, first down the chondrogenic pathway and later down the osteogenic 
pathway.   
In vitro studies have also provided evidence for loading influences on developmental 
regulation.  Intermittent hydrostatic pressure applied to organ cultures of fetal long bone 
rudiments increased mineralized bone formation, which could be due in part to enhanced 
osteogenesis in these cultures [144].  Enhanced expression of markers for chondrogenesis 
were observed in chick limb bud cultures subjected to intermittent cyclic compressive 
loading, but not static loading, [19] and in mouse limb bud cultures subjected to constant 
static compression [20].  Additionally, a theory has been developed which describes how 
differences in local tissue mechanical stresses guide skeletal tissue development, growth, 
maintenance, and repair [18].   
Based upon these observations from normal skeletal development and repair, 
mechanical stimulation may be an important factor influencing MPC differentiation and 
subsequent tissue development.  A number of recent in vitro studies have evaluated 
mechanical loading influences on MPCs and other progenitor populations.  Human 
marrow stromal cells subjected to oscillatory fluid flow exhibited increased proliferation 
and increased osteopontin and osteocalcin mRNA levels, markers of the osteoblast 
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phenotype [145].  Bovine bone marrow stromal cells cultured in chondrogenic media 
demonstrated increased gene expression for the chondrogenic markers aggrecan and type 
II collagen upon exposure to hydrostatic pressurization, but application of pressure alone 
was not sufficient to initiate differentiation [146].  Cyclic uniaxial strain transiently 
increased the expression of smooth muscle α-actin and smooth muscle-22α in MPCs 
after 1 day, while equiaxial strain downregulated expression of the smooth muscle cell 
markers [147].  Application of both rotational and translational strains, in the absence of 
specific chemical factors, led to the expression of collagen types I and III and tenascin-C, 
markers of ligament fibroblasts [148].  The results also showed evidence for ligament 
tissue development, including cellular alignment and formation of oriented collagen 
fibers, in response to mechanical stimulation for 21 days.  Overall, these studies provide 




CHAPTER 3  
TGF-β1 AND DEXAMETHASONE INFLUENCES ON IN VITRO GOAT MPC 
CHONDROGENIC DIFFERENTIATION AND MATRIX ACCUMULATION 
 
Introduction 
Mesenchymal progenitor cells (MPCs) are a promising cell source for orthopaedic 
tissue engineering therapies.  MPCs associated with a carrier matrix have been shown to 
support new tissue formation in repair models for bone, cartilage, meniscus, and tendon 
[108, 149-151].  In vitro manipulations of MPCs have been utilized to initiate cellular 
differentiation and to promote development of tissue-engineered implants [82, 110].  In 
response to specific chemical cues, MPCs have been shown to undergo in vitro 
commitment to multiple mesenchymal cell lineages, including osteoblasts, chondrocytes, 
and adipocytes [113].   
In vitro chondrogenic differentiation stimulated by growth factor supplementation has 
been demonstrated in marrow-derived MPCs for human, rabbit, equine, porcine, bovine, 
and goat donors [11, 12, 29, 110, 111, 152, 153].  In vitro chondrogenesis has been 
supported in a variety of culture systems.  These include scaffold-free cultures such as 
high-density monolayers and micromass pellets [11, 153, 154], biomatrices such as 
alginate, gelatin, and hyaluronan [38, 155, 156], and polymeric scaffolds such as PGA, 
PLLA, and PLGA/PEG [25, 110, 157].  The majority of in vitro studies have been 
performed with human MPCs, in part to demonstrate the feasibility of developing either 
cell transplantation or tissue engineering strategies for cartilage repair utilizing MPCs.  
Ultimately, the development of cartilage repair strategies based upon MPCs will include 
preclinical testing in appropriate cartilage defect models.  Preclinical testing will be 
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supported by in vitro validation of chondrogenic differentiation in nonhuman MPC 
sources and by evaluation of differentiating MPCs in 3-D culture systems appropriate for 
cartilage tissue engineering applications. 
This chapter explores TGF-β1 and dexamethasone (Dex) influences on in vitro goat 
MPC chondrogenic differentiation and subsequent matrix accumulation in alginate 
suspension.  This work was guided by established human MPC protocols, which 
routinely used a combination of TGF-β (isoforms 1, 2, or 3) and Dex in ITS+-containing 
media to promote chondrogenic differentiation of MPCs in various 3-D culture systems 
[11, 12, 25].  One objective of this work was to define culture media conditions that 
supported MPC chondrogenic differentiation and that enhanced matrix accumulation by 
differentiating MPCs in hydrogel suspension.  The number of supplements provided 
(single versus multiple supplements) and the duration over which supplements were 
provided (early versus entire culture period) were variables evaluated in defining the 
culture media conditions.  Criteria for comparison of culture media conditions included 
the ability to support production of cartilage matrix components and the amount of matrix 
accumulation.   
A second objective of this work was to establish a time course for matrix synthesis 
and accumulation by MPCs undergoing chondrogenic differentiation and subsequently 
expressing a chondrogenic phenotype.  A four-week study was therefore conducted 
utilizing the defined culture media conditions identified in the first objective.  Multiple 
MPC donors were evaluated, in part to provide an assessment of donor variability.  
Overall, the studies conducted in this chapter provided knowledge about goat MPCs 
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undergoing chondrogenic differentiation in alginate suspension, which would be 
important to planning of future loading studies.    
The evaluation of chondrogenic differentiation utilized biochemical analyses and 
histological analyses to validate the production of the two major structural components of 
articular cartilage: proteoglycans and type II collagen.  Proteoglycan production was 
assessed quantitatively by determining proteoglycan synthesis, measured as the 35S-
sulfate incorporation rate, and sulfated glycosaminoglycan (sGAG) accumulation.  Type 
II collagen production was assessed qualitatively with immunohistochemical staining.  
Protein synthesis, measured as the 3H-proline incorporation rate, and DNA content were 
also evaluated as general culture markers.   
Methods 
Materials 
Goat MPCs were provided by Osiris Therapeutics, Baltimore, MD.  All media, trypsin, 
PBS, culture additives (unless noted otherwise), and pepsin were from Invitrogen Life 
Technologies, Chicago, IL.  FBS was from Hyclone, Logan, UT.  Ascorbic acid-2-
phosphate, L-proline, papain, 1,9-dimethyl-methylene blue (DMMB), chondroitin sulfate 
A, and buffer reagents for the biochemical analyses were from Sigma-Aldrich, St. Louis, 
MO.  ITS+ premix was from BD Biosciences, Bedford, MA.  Recombinant human TGF-
β1 and recombinant human FGF basic were from R&D Systems, Minneapolis, MN.  
Pronova UP LVG alginate was from NovaMatrix, FMC BioPolymer, Norway.  L-5-3H-
proline was from Amersham Biosciences, Piscataway, NJ.  35S-sodium sulfate and 
Ecolume were from MP Biomedical, Irvine, CA.  The Live-Dead kit and the PicoGreen 
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kit were from Molecular Probes, Eugene, OR.  Immunohistochemistry reagents were 
from Vector Labs, Burlingame, CA.  
MPC Isolation and Expansion  
Osiris Therapeutics conducted the goat MPC isolation from iliac crest bone          marrow 
aspirates followed by adherent primary expansion as described in their published 
methods for human MPCs [38].  It should be noted that goat MPC donors provided for 
use in these studies had been subjected to a screening process to verify their ability to 
undergo chondrogenic differentiation (personal communication with Osiris 
Therapeutics).  Following primary culture, the cells were expanded for two passages 
(plating density 2700cells/cm2) in low glucose DMEM with 110mg/L sodium pyruvate 
and 584ml/L glutamine containing 10% FBS, 1% antibiotic/antimycotic (100units/ml 
penicillin, 100μg/ml streptomycin, 0.25μg/ml amphotericinB), and 1ng/ml FGF-2.  The 
use of FGF-2 was based upon previous work with canine MPCs (see Appendix A) and 
upon other studies in the literature demonstrating a positive effect for FGF-2 on 
maintenance of MPC differentiation potential following monolayer expansion [123, 158].  
When cells had reached a near-confluent density, the flasks were incubated with 0.42g/L 
trypsin, 0.44mM EDTA·4Na in Ca2+-free, Mg2+-free PBS followed by rinsing in standard 
expansion media to yield a single cell suspension.  
3-D MPC Culture 
Passage 2 MPCs were suspended in one part Ca2+-free, Mg2+-free PBS and mixed with 2 
parts 3% Pronova UP LVG alginate (prepared in Ca2+-free, Mg2+-free PBS and filter 
sterilized) to yield a cell suspension of 12.5x106cells/ml.  The 2% alginate concentration, 
somewhat higher than the 1.2% concentration used previously with MPCs, was consistent 
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with alginate formulations used in mechanical loading studies with chondrocytes.  The 
seeding concentration used was determined empirically by selecting a concentration that 
was an intermediate value for the range of concentrations used previously for hydrogel 
suspension of chondrocytes and MPCs.  The cell suspension (25-45μl depending on 
desired thickness) was transferred to individual 4mm diameter wells of a custom-
designed casting mold (Figure 1).  The casting mold consisted of four pieces (as 
assembled from bottom to top): solid polycarbonate base, wire mesh, cellulose acetate 
membrane filter (0.2 micron pore size), and a top polycarbonate piece with a 4x4 grid of 
4mm diameter holes drilled out.  The filter was wet with the polymerization solution 
(102mM CaCl2, 10mM Hepes, 100mM NaCl) prior to addition of the cell suspension.  
After ~25 minutes of incubation, polymerization solution was added to the top of the 
wells.  Gels were removed from the wells after a total incubation of ~60 minutes and 
incubated in 150mM NaCl for ~40 minutes, followed by incubation in chondrogenic 
media excluding the ascorbic acid-2-phosphate, Dex, and TGF-β1 (see below) for ~40 
minutes.  Gels were then transferred to 48-well plates and cultured throughout the study 
in chondrogenic media: high glucose DMEM with 110mg/L sodium pyruvate and 
584ml/L glutamine containing 1% ITS+ premix (6.25μg/ml insulin, 6.25μg/ml transferrin, 
6.25ng/ml selenious acid, 1.25mg/ml bovine serum albumin, 5.35mg/ml linoleic acid), 
1% antibiotic-antimycotic, 40μg/ml L-proline, and 50μg/ml ascorbic acid-2-phosphate.  
Chondrogenic supplements evaluated were 100nM Dex and 10ng/ml TGF-β1 as per 





TGF-β1 and Dex effects on chondrogenic differentiation and subsequent matrix 
accumulation were explored in a series of four studies (Table 1).  At the designated 
harvest time in all studies, gels were either subjected to biochemical or histological 
analyses. 
Study 1: Media Supplement Comparison 
Media formulations were compared with regard to the ability to support MPC 
chondrogenic differentiation.  Media lacking supplements was compared to media 
continuously supplemented with Dex only, with TGF-β1 only, and with both Dex and 
TGF-β1.  Gels were cultured for 14 days (2 donors; 1 experiment/donor). 
Study 2: Duration of Dex Supplementation   
Since the first study indicated that Dex had a negative effect on the progression of 
chondrogenic differentiation for TGF-β1 supplemented cultures, a study was 
subsequently conducted to more thoroughly examine whether some combination of Dex 
and TGF-β1 supplementation would support progression of chondrogenic differentiation 
in a manner comparable to that supported by TGF-β1 alone.  In this study, the duration of 
Dex supplementation was varied, while TGF-β1 supplementation was continuous.  Gels 
were initially cultured with TGF-β1 or with Dex and TGF-β1.  Dex was removed from 
the supplemented media at a designated culture time (day 2, day 4, or day 7) and all gels 
were grown to day 14 (1 donor; 1 experiment).   
Study 3: Duration of TGF-β1 Supplementation 
Since the first study demonstrated that TGF-β1 was stimulatory for MPC chondrogenic 
differentiation, a study was subsequently conducted to determine if the stimulatory action 
 29
of TGF-β1 was dependent on continuous supplementation, thereby providing greater 
understanding about TGF-β1 influences on MPC cultures.  In this study, removing TGF-
β1 at either culture day 4 or day 7 was compared to continuous TGF-β1 supplementation 
in day 14 cultures (1 donor; 1 experiment). 
Study 4: Time Course of MPC Matrix Synthesis and Accumulation 
In the preceding studies, chondrogenic differentiation and matrix accumulation were 
analyzed at culture day 14.  However, preparation for the loading studies necessitated 
understanding how synthesis and accumulation of cartilage matrix components changed 
with time for MPCs cultured with chondrogenic media.  A study was thus conducted 
evaluating MPC/alginate cultures subjected to continuous TGF-β1 supplementation and 
grown to 28 days, with samples harvested at multiple time points (2 donors; 1 
experiment/donor).   
Radiolabel Incorporation  
At harvest, samples for biochemical analyses (n=3-4 per condition per donor) were 
transferred to 96 well plates and incubated for 20 hours in 0.5ml culture media 
additionally containing 20μCi/ml L-5-3H-proline and 10μCi/ml 35S-sodium sulfate.  At 
the end of the incubation period, the samples were transferred to new culture wells 
containing 1 ml of radiolabel quench solution, which was PBS additionally containing 
0.8mM sodium sulfate and 1.0mM L-proline.  Samples were washed in a total of four 
fresh aliquots of quench solution for ~30 minutes per wash.  Samples were then 





Gels were lyophilized, weighed, resuspended in papain digest solution (150mM sodium 
phosphate dibasic, 5mM Na2EDTA, 5mM n-acetyl-L-cysteine pH 6.5 containing ~1.7 
units papain per sample), and incubated at 60ºC for 24 hours.  For radiolabel 
incorporation measurements, 100μl of the sample digest was added to 2 ml Ecolume in a 
scintillation vial.  Raw counts in CPM were obtained for each sample using a liquid 
scintillation counter.  3H and 35S activity were calculated from the raw counts based upon 
standard curves prepared from serial dilutions of the original radiolabeled media.  The 
activities were then converted into 3H-proline and 35S-sulfate incorporation rates.  
Double-stranded DNA content was determined using the PicoGreen assay and quantified 
against a lambda DNA standard curve.  A 1:20 sample dilution was prepared in the base 
digest buffer.  100μl sample dilution was mixed with 100μl PicoGreen reagent (prepared 
in 1X TE buffer according to the vendor instructions).  The mixture was incubated for 10 
minutes and then measured on a Perkin-Elmer HTS 7000plus plate reader (excitation at 
485nm; emission at 535nm).  sGAG content was determined using a modified DMMB 
assay appropriate for use with alginate-containing samples [159].  sGAG content in 
experimental samples was quantified against a chondroitin-4-sulfate standard from 
bovine cartilage.  Alginate, at a concentration matching that in the sample dilutions, was 
included in the buffer used to create the chondroitin-4-sulfate standard curve to account 
for any interaction between the dye and alginate.  Sample dilutions were prepared as 
necessary in the base digest buffer.  200μl dye (~21mg/L dye in 29mM sodium formate, 
pH 1.5 adjusted with formic acid) was added to 20μl sample dilution in a 96-well plate 
and then measured immediately at 525nm on a Bio-Tek PowerWave X340 plate reader. 
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Cell Viability Staining  
In selected studies control gels were rinsed in PBS three times for 10 minutes per rinse, 
halved, stained with a Live-Dead kit utilizing 4μM calcein and 4μM ethidium 
homodimer, and subsequently rinsed in PBS three times for 10 minutes per rinse.  To 
assess cellular viability at the designated culture time, the stained gels were imaged on a 
Zeiss LSM 510 confocal microscope.    
Histological Analyses 
At harvest, samples for histological analyses (n=1-2 per condition per donor) were 
halved.  Gel halves were rinsed in PBS, soaked in 100mM BaCl2 for ~45 minutes to 
stabilize crosslinking of the alginate gel, rinsed in PBS, transferred to 10% neutral-
buffered formalin for 36-48 hours, rinsed in PBS and stored in 70% alcohol.  Samples 
were subsequently embedded in paraffin and sectioned at 5μm for analysis.  
Immunohistochemical assays were performed (see Appendix B for protocol) with a 
monoclonal antibody provided by the Developmental Studies Hybridoma Bank for Type 
II collagen (IgG II-II6B3).  Following deparaffinization and rehydration, tissue sections 
were incubated in pepsin for ten minutes and the incubation was repeated a second time.  
Presence of the antigen was detected as an alkaline phosphatase deposit.  To control for 
nonspecific staining, one slide per batch was incubated with blocking serum rather than 
the primary antibody and then processed identically with the other slides.  Positive and 
negative control slides were also included.     
Statistical Analyses 
Data were analyzed using a general linear ANOVA model with Tukey’s test for post-hoc 
analysis (significance at p<0.05), where the effect of media condition (or culture day for 
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the time course study) on the biochemical parameter of interest was evaluated for a given 
MPC donor in each study. 
Results 
Media Supplement Comparison 
Continuous supplementation with Dex or TGF-β1 was compared to growth in 
baseline media containing ascorbic acid-2-phosphate (AA2P) for day 14 MPC cultures.  
Chondrogenic differentiation was supported by TGF-β1 supplementation, but was not 
supported by Dex supplementation or by the AA2P baseline media (Table 2, data shown 
for donor G115).  Chondrogenic differentiation was demonstrated by a 20-fold increase 
in 35S-sulfate incorporation from day 1 to day 14, by sGAG/DNA accumulation, and by 
staining for type II collagen (Figure 2).  The inclusion of TGF-β1 in the culture media 
also promoted cellular proliferation, as DNA content increased 30% (p<0.001) from day 
1 to day 14.  Conversely, DNA content decreased from Day 1 to Day 14 in both the Dex 
and AA2P groups (67% and 72% respectively; p<0.001).  Live/Dead staining 
demonstrated that cell viability was initially high in the day 1 cultures, while at day 14 a 
majority of cells were viable in the TGF-β1 cultures, a minority of cells were viable in 
the Dex cultures, and very few cells were viable in the AA2P cultures (Figure 3).        
Continuous supplementation with TGF-β1 was further compared to continuous 
supplementation with both Dex and TGF-β1 (D&T) for day 14 MPC cultures.  Matrix 
synthesis and accumulation were markedly reduced in the Dex-containing media (Figure 
4).  The addition of Dex to media supplemented with TGF-β1 decreased 35S-sulfate 
incorporation (85% for donor G115; 66% for donor G151; p<0.001) and similarly 
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decreased sGAG/DNA (89% for donor G115; 71% for donor G151; p<0.001) compared 
to culture in TGF-β1 alone.  There were no significant differences in DNA content 
between the D&T and TGF-β1 groups (data not shown).  Positive staining for type II 
collagen was present around a majority of cells for the TGF-β1 supplemented media but 
was present around only a very limited number of cells for the D&T supplemented media 
(Figure 2), indicating that the MPC/alginate cultures exposed to both Dex and TGF-β1 
had progressed more slowly in the differentiation process than cultures exposed to TGF-
β1 alone by culture day 14. 
Duration of Dex Supplementation     
The initial study indicated that Dex had a negative effect on the progression of 
chondrogenic differentiation for TGF-β1 supplemented cultures.  However, the dose of 
Dex, which would depend on both supplement concentration and duration, may have 
influenced the response of the MPC cultures.  The duration of Dex supplementation was 
subsequently evaluated in combination with continuous TGF-β1 supplementation to 
determine if some combination of Dex and TGF-β1 could support progression of 
chondrogenic differentiation in a manner comparable to that supported by TGF-β1 alone 
and/or could be beneficial for MPC matrix synthesis and accumulation in alginate 
suspension as compared to levels promoted by TGF-β1 alone.  Removal of Dex from the 
culture media after two, four, or seven days of culture (i.e. Dex 0-2, Dex 0-4, Dex 0-7) 
resulted in 35S-sulfate incorporation and DNA levels that were comparable to the No Dex 
(i.e. TGF-β1 only) group at day 14 (Figure 5; DNA data not shown).  In contrast, 
sGAG/DNA was more sensitive to Dex duration.  Both the Dex 0-4 and the Dex 0-7 
groups had lower sGAG/DNA levels compared to the No Dex group (17% and 50% 
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decrease respectively; p<0.02), while sGAG/DNA for the Dex 0-2 group was comparable 
to the No Dex group.  Consistent with the previous study, the cultures that received Dex 
throughout the study (Dex 0-14) had 69% lower 35S-sulfate incorporation (p<0.001) and 
75% lower sGAG/DNA (p<0.001) compared to the No Dex group, while DNA content 
was comparable across the two groups (data not shown).  Positive staining for type II 
collagen was present around a majority of cells in the No Dex gels, the Dex 0-2 gels, and 
the Dex 0-4 gels (Figure 5).  In contrast, a minority of cells exhibited positive staining in 
the Dex 0-7 gels, while only a very limited number of cells exhibited positive staining in 
the Dex 0-14 gels.  The type II collagen staining indicated that the negative effect of Dex 
on the progression of chondrogenic differentiation in response to TGF-β1 required the 
extended presence of Dex in the culture media.  However, shorter periods of Dex 
supplementation in combination with continuous TGF-β1 supplementation were not 
found to have a positive effect on either 35S-sulfate incorporation or sGAG/DNA content 
as compared to TGF-β1 alone.  Since there was no compelling reason to use Dex, even 
for a short duration, to support either MPC chondrogenic differentiation or matrix 
accumulation, Dex was excluded from the culture media in all subsequent studies. 
Duration of TGF-β1 Supplementation  
While the initial study demonstrated that TGF-β1 was stimulatory for MPC 
chondrogenic differentiation, it was unknown if continuous TGF-β1 supplementation was 
necessary as compared to a shortened duration of TGF-β1 supplementation.  
Furthermore, it was uknown if sustained TGF-β1 supplementation in a serum-free culture 
media was beneficial for MPC matrix synthesis and accumulation in hydrogel 
suspension.  The duration of TGF-β1 supplementation was subsequently evaluated.  
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TGF-β1 was included throughout the 14 day culture period (TGF 0-14) or was removed 
from the media beginning on Day 4 (TGF 0-4) or Day 7 (TGF 0-7).  To demonstrate 
changes in time with supplementation, baseline gels were analyzed at day 4.  Comparing 
the day 14 culture groups (Table 3) to the day 4 baseline showed that 35S-sulfate 
incorporation had approximately doubled at day 14 from the day 4 level of 
0.1034±0.0073 pmol/ngDNA/hr and sGAG content had increased in the range of 23- to 
28-fold at day 14 from the day 4 level of 8.0±1.4 μg/gel for the range of TGF-β1 
supplement durations evaluated.  These increases, together with the detection of type II 
collagen staining in all day 14 cultures (not shown), indicated that the progression of 
chondrogenic differentiation from day 4 to day 14 was maintained in MPC cultures for all 
durations of TGF-β1 supplementation evaluated.  However, differences in matrix 
synthesis and accumulation were noted between the day 14 culture groups.  TGF-β1 
supplementation beyond the initial 4 days in culture led to an increase in 35S-sulfate 
incorporation (11% for TGF 0-7; 13% for TGF 0-14; p<0.02) and sGAG content (16% 
for TGF 0-7; 21% for TGF 0-14; p<0.05) compared to the TGF 0-4 group, while both 
parameters were comparable between the TGF 0-7 and TGF 0-14 groups.  The extended 
use of TGF-β1 also increased the DNA content compared to the TGF 0-4 group (34% for 
TGF 0-7; 73% for TGF 0-14; p<0.002) and compared to the TGF 0-7 group (29% for 
TGF 0-14; p<0.001).  Therefore, per cell sGAG accumulation (sGAG/DNA) was 
increased in the TGF 0-4 group compared to the other groups (15% versus TGF 0-7; 42% 
versus TGF 0-14; p<0.02) and in the TGF 0-7 group compared to the TGF 0-14 group 
(24%; p<0.003).  This study demonstrated that an initial 4 day period of TGF-β1 
supplementation was a sufficient stimulus for chondrogenic differentiation.  However, 
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continuous TGF-β1 supplementation was chosen as the chondrogenic stimulus for 
subsequent studies due to the noted enhancements in 35S-sulfate incorporation and sGAG 
content corresponding to extended TGF-β1 supplementation.   
Time Course of MPC Matrix Synthesis and Accumulation 
In the preceding studies, chondrogenic differentiation and matrix accumulation were 
evaluated at culture day 14.  However, it was planned that the loading studies would 
compare differentiating MPC cultures demonstrating different levels of matrix 
production, requiring an understanding of how matrix synthesis and accumulation 
changed with time in culture.  Therefore, a study was conducted to evaluate matrix 
synthesis and accumulation for MPC/alginate cultures continuously supplemented with 
TGF-β1 over a four-week period (Figures 6 and 7, data shown for donors G115 and 
G117).  Cartilage matrix components appeared during the first week of culture.  Gels at 
culture day 1 exhibited low 35S-sulfate incorporation and were lacking both sGAG/DNA 
accumulation and type II collagen staining.  With additional culture to day 4, gels 
exhibited intermediate 35S-sulfate incorporation and low sGAG/DNA accumulation, but 
were lacking type II collagen staining.  With further culture to day 7, gels exhibited peak 
or near-peak 35S-sulfate incorporation (4.8-fold and 2.7-fold increase from day 4 to day 7 
for donors G115 and G117 respectively; p<0.001), increasing sGAG/DNA accumulation 
(8.6-fold and 6.7-fold increase from day 4 to day 7 for donors G115 and G117 
respectively; p<0.02), and a low level of type II collagen staining.  Comparing the time 
course for individual donors indicated strong similarities between them during the first 
week of culture.         
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Further changes in matrix synthesis and accumulation occurred from day 7 to day 28 
and some differences were noted between the two donors.  For donor G115, 35S-sulfate 
incorporation further increased 29% from day 7 to day 14 (p<0.001) and then decreased 
10% from day 14 to day 28 (p<0.003).  For donor G117, 35S-sulfate incorporation 
decreased 18% from day 7 to 14 (p<0.001) and then further decreased 34% from day 14 
to day 28 (p<0.001).  Despite the differences in 35S-sulfate incorporation, sGAG/DNA 
increased steadily from day 7 to day 28 in both donors.  DNA content increased from day 
7 to day 14 (48% for donor G115; 59% for donor G117; p<0.001), then decreased 10% 
(p<0.02) for donor G115 from day 14 to day 28 but did not change for donor G117.  3H-
proline incorporation decreased from day 7 to day 14 (29% for donor G115; 44% for 
donor G117; p<0.001), then increased from day 14 to day 28 (120% for donor G115; 
47% for donor G117; p<0.001).  Type II collagen was detected surrounding a limited 
number of cells at day 7 and a majority of cells at day 14, with pericellular staining 
increasing through day 28 (Figure 7). 
Discussion 
Marrow-derived MPCs are a promising cell source for cartilage tissue engineering 
strategies and much research has focused on characterizing in vitro chondrogenic 
differentiation of human MPCs.  However, preclinical testing of cartilage repair strategies 
utilizing MPCs necessitates the establishment in vitro culture systems promoting 
chondrogenic differentiation of nonhuman MPCs.  Goats have been used increasingly for 
cartilage repair studies in recent years.  While previous studies have demonstrated in vitro 
chondrogenic differentiation of goat MPCs [29, 30], knowledge about the effects of 
specific media components on differentiation is limited.  This chapter evaluated in vitro 
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goat MPC chondrogenic differentiation and subsequent matrix accumulation in alginate 
suspension in response to TGF-β1 and Dex supplementation.           
This work provided biochemical and immunohistochemical evidence that goat 
MPC/alginate cultures exposed to TGF-β1 supplementation undergo chondrogenic 
differentiation.  TGF-β1 was found to be sufficient to support differentiation, without 
additional supplementation with Dex.  This result is in contrast to prior work with human 
MPC pellet cultures, which were shown to require both TGF-β and Dex for 
differentiation [12], but is consistent with prior work in rabbit MPC pellet cultures [153].  
Previous in vitro studies by other groups typically evaluated MPC chondrogenic 
differentiation in response to continuous growth factor and glucocorticoid 
supplementation.  However, one group reported that human MPCs seeded in 
polylactide/alginate amalgam underwent chondrogenic differentiation with exposure to 
50 ng/ml TGF-β1 for the initial three days of culture, a dose of TGF-β1 five times higher 
than the concentration used for continuous supplementation [25].  Our results indicated 
that continuous supplementation with 10ng/ml TGF-β1 was not a requirement for 
differentiation of goat MPCs.  Rather, commitment to the chondrogenic lineage in 
response to TGF-β1 supplementation appeared to occur rapidly in the goat MPC/alginate 
cultures, as progression of chondrogenic differentiation evidenced by extensive type II 
collagen staining in day 14 cultures was maintained following TGF-β1 removal after 4 or 
7 days in culture.   
The primary role of TGF-β1 in MPC chondrogenesis is consistent with previous 
studies in other undifferentiated cell populations.  TGF-β1 and other members of the 
TGF-β family have promoted in vitro chondrogenesis in a variety of progenitor cell 
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populations, including limb bud cultures, mesenchymal cell lines, and periosteal explants 
[54, 56, 57, 160-164].  While the effects of TGF-β1 on chondrogenic differentiation are 
well established, the mechanisms that underlie these effects are only beginning to be 
explored.  The expression of TGF-β receptors by human MPCs has been verified [39, 
165].  Recent reports have demonstrated the importance of MAP kinase signaling 
cascades and Wnt signaling pathways in mediating the actions of TGF-β1 on MPC 
chondrogenic differentiation [166, 167]. 
The sustained presence of TGF-β1 in the culture media could mediate changes in the 
MPC cultures beyond those overtly related to differentiation.  TGF-β1 has been shown to 
influence proliferation and extracellular matrix synthesis in numerous cell types [168-
172].  More specifically related to cartilage, TGF-β1 has been demonstrated to support 
proliferation of both MPCs [110, 173, 174] and articular chondrocytes [175-177].  Our 
work showed that TGF-β1 supported proliferation of goat MPCs in alginate suspension.  
The influence of TGF-β1 on matrix production by primary articular chondrocytes has 
been variable [178].  In some cultures matrix production was stimulated and in other 
cultures production was inhibited with exposure to TGF-β1 [179-182].  Our work 
demonstrated a stimulation of proteoglycan synthesis in day 14 MPC/alginate cultures for 
continuous TGF-β1 supplementation as compared to supplementation only during the 
initial four days in culture.  Overall, the evaluation of TGF-β1 effects on matrix 
production in differentiating MPC cultures was very limited in our work and focused on 
varying the duration of supplementatation at a single concentration (10ng/ml).  However, 
the concentration of TGF-β1 most appropriate for initiating chondrogenic differentiation 
in MPC cultures could be different from the concentration most appropriate for 
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stimulating matrix production in committed MPC cultures.  Furthermore, once the MPCs 
have become differentiated chondrocytes, other growth factors shown previously to 
stimulate matrix production by primary chondrocytes, such as IGF-I [101], could be more 
benefical than TGF-β1 for extended MPC culture.  Although these considerations were 
beyond the scope of the thesis work, such issues could be critical to the in vitro 
development of tissue-engineered cartilage constructs utilizing MPCs.  
While the TGF-β1 effects on goat MPCs were consistent with previous studies, the 
Dex effects on goat MPCs were notably different.  To our knowledge, our work is the 
first to report a negative influence for Dex on TGF-β1 stimulated chondrogenic 
differentiation of marrow-derived MPCs.  Continuous Dex supplementation slowed, but 
did not completely disrupt, differentiation of the goat MPC/alginate cultures.  Extended 
culture in Dex and TGF-β1 may have supported further progression of differentiation of 
the MPC cultures.  A recent study reported chondrogenic differentiation of goat 
MPC/hydrogel cultures after six weeks of supplementation with Dex and TGF-β1 [183].  
Our work also demonstrated that Dex supplementation, when shortened to the initial two 
to four days of culture, supported chondrogenic differentiation and subsequent matrix 
accumulation similarly to culture in the absence of Dex for MPCs continuously 
supplemented with TGF-β1.  Although altering the Dex concentration from the standard 
concentration of 100nM used in this work and previous studies could possibly support 
enhanced matrix production by differentiating MPCs, the levels of matrix synthesis and 
accumulation supported by TGF-β1 alone were considered to be sufficient for the 
purposes of the thesis work and the Dex issue was not explored further.    
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The culmination of the results from the studies evaluating TGF-β1 and Dex effects 
demonstrated that continuous TGF-β1 supplementation in media lacking Dex was the 
best culture media for goat MPC chondrogenic differentiation and matrix accumulation 
based upon the supplement levels and durations evaluated.  This culture media was 
shown to support the appearance of cartilage matrix components during the first week of 
culture.  Culture from day 7 to day 14 supported further progression of chondrogenic 
differentiation as related to type II collagen expression, while culture beyond day 14 
contributed to matrix accumulation.  The timing study further demonstrated that 
distinctions could be made between MPC cultures at days 1, 4, and 7 as related to 
proteoglycan synthesis, sGAG/DNA accumulation, and type II collagen expression.  
Given the limited exposure to TGF-β1 supplementation, the day 1 culture could be 
described as a prechondrogenic culture.  The increase in proteoglycan synthesis and the 
detection of sGAG/DNA accumulation at day 4 represented changes by a differentiating 
culture, while the appearance of type II collagen at culture day 7 indicated a further 
progression of chondrogenic differentiation.  Although MPCs at these three culture times 
have unique biosynthetic profiles, it is unknown whether MPCs at these different culture 
times are distinct in other ways, such as their ability to respond to a variety of external 
factors, including mechanical stimuli.   
In conclusion, TGF-β1 was demonstrated to be a potent stimulator of chondrogenic 
differentiation in goat MPC/alginate cultures.  The chondrogenic response to TGF-β1 
was notably enhanced by the exclusion of Dex, a factor used routinely with MPCs from 
other species.  Importantly, the work conducted in this chapter provided the experimental 
foundation upon which the remaining thesis work was built.  Having established an 
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appropriate culture media to promote chondrogenic differentiation and having gained a 
basic understanding regarding the progression of differentiation and matrix accumulation 
in the alginate culture system, explorations into how differentiating MPC cultures might 






























Figure 1: Gel Casting Mold. Top: The mold consists of a top piece with 4mm diameter 
holes drilled out, a cellulose acetate membrane filter, a wire mesh, and a solid base piece 
(shown clockwise from upper left) and is held together by screws. Bottom left: 
Cell/alginate suspension is pipetted into the wells of the assembled mold after the filter is 
wet with a polymerization solution. Bottom right: After polymerization, the mold is 
disassembled and the cylindrical gels are removed from the wells by pushing a rod 
through the bottom of each well. 
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Table 1: Summary of Studies Evaluating TGF-β1 and Dex Effects. In the first 3 
studies, cultures were harvested for comparison on day 14 only. 
 
 Experimental Variable Levels Evaluated 
Study 1 Media Supplement Dex;  TGF-β1; Dex & TGF-β1; 
Comparison to baseline media 
with ascorbic acid-2-phosphate 
Study 2 Days of Dex Supplementation 
Note: All cultures received TGF-β1 
Dex starting on day 0 
for 0, 2, 4, 7, or 14 days 
Study 3 Days of TGF-β1 Supplementation 
 
TGF-β1 starting on day 0  
for 4, 7, or 14 days 
Study 4 Days in Culture 
Note: All cultures received TGF-β1 









Table 2: Day 14 Evaluation of Media Supplements for Chondrogenic Differentiation 
Potential. Continuous supplementation with Dex or TGF-β1 was compared to growth in 
baseline media containing ascorbic acid-2-phosphate (AA2P).  Baseline data for day 1 
cultures are provided to demonstrate changes in time with supplementation. (mean ± 
SEM; n=4gels/supplement; data shown for donor G115).  Undetectable indicates that the 











AA2P 1005 ± 12 Undetectable Undetectable 0.0027 ± 0.0001 
Dex 1198 ± 9 Undetectable Undetectable 0.0103 ± 0.0007 
TGF-β1 4730 ± 37 219.7 ± 11.3 46.4 ± 2.2 0.3475 ± 0.0096 
















Figure 2: Type II Collagen Staining of Day 14 Cultures Comparing Chondrogenic 
Media Conditions. Type II collagen immunostaining (20X; red coloration indicates 
presence of antigen; images shown for donor G115) for cultures supplemented with TGF-
β1 only or with Dex & TGF-β1.     
 


































Figure 3: Cell Viability Staining of Cultures Grown in Different Media Conditions.  
Live/Dead staining (10X; images shown for donor G115) comparing viability in Day 1 
control cultures to Day 14 cultures grown in baseline media with ascorbic acid-2-
phosphate, in media with Dex, or in media with TGF-β1.  Green staining (calcein AM) 
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Figure 4: Biochemical Analyses Comparing Chondrogenic Media Conditions. 
Cultures were supplemented with TGF-β1 only or with Dex & TGF-β1 in two MPC 
donors. Bars represent mean ± SEM (n=4gels/donor/supplement; 1 experiment). * 


















































Figure 5: Evaluation of Day 14 Cultures in Response to Varying the Duration of Dex 
Supplementation. Dex was excluded from the media (No Dex), was included for the 
initial 2, 4, or 7 days of culture, or was included throughout the culture period (Dex Day 
0-14). All cultures were supplemented with TGF-β1. Top: Evaluation of 35S-sulfate 
incorporation and sGAG/DNA. Bars represent mean ± SEM (n=4gels/supplement; 1 
experiment). * denotes significantly different versus No Dex. Bottom: Type II collagen 




 No Dex                                Dex Day 0-2                           Dex Day 0-4
 Dex Day 0-7                           Dex Day 0-14 
 49
Table 3: Evaluation of Day 14 Cultures in Response to Varying the Duration of 
TGF-β1 Supplementation. TGF-β1 was included throughout the culture period (0-14) 
or was removed from the media beginning on day 4 (0-4) or day 7 (0-7). Values are mean 












TGF-β1 0-14   6155 ± 196  220.0 ± 3.0   35.8 ± 0.8  0.2313 ± 0.0056 
TGF-β1 0-7 * 4768 ± 213  211.2 ± 10.3 * 44.4 ± 1.8  0.2275 ± 0.0046 









































































































Figure 6: Time Course of Biosynthesis and Matrix Accumulation for MPC Cultures 
undergoing Chondrogenic Differentiation. Cultures were grown from 1 day to 4 weeks 
in media supplemented with TGF-β1 for two MPC donors (G115 and G117). Note that 
day 1 cultures were excluded from the experiment for donor G117. Values are mean ± 


























Figure 7: Time Course of Type II Collagen Staining in Chondrogenic Cultures.  
Type II collagen immunostaining (20X; red coloration indicates presence of antigen; 
shown for donor G117) for cultures supplemented with TGF-β1 and grown to days 7, 14, 
and 28. 
 Day 14                                                     Day 28  
                              Day 7 
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CHAPTER 4  




Recent strategies for cartilage tissue engineering have utilized adult mesenchymal 
progenitor cells (MPCs) in combination with chondrogenic growth factors and an 
appropriate scaffold to support in vitro cellular differentiation and tissue development 
[137, 155, 184].  Mechanical preconditioning has been proposed as a stimulatory factor 
for the development of tissue-engineered cartilage constructs and articular chondrocytes 
have been shown to produce an enhanced cartilage matrix when subjected to long-term 
oscillatory compressive loading [15-17].  However, little is known about the ability of 
mechanical signals to influence MPC chondrogenic differentiation and matrix 
accumulation in vitro.   
A growing body of evidence indicates that mechanical signals direct in vivo 
development and repair of orthopaedic tissues, which may be mediated in part by 
influences on lineage commitment and progression of mesenchymal progenitor 
populations.  In prenatal development, muscular contractions provide loading of 
appendicular skeletal elements [18].  This stimulation may be critical in guiding limb 
expansion, as paralysis of chick embryos leads to reduced long bone growth [140, 141].  
Tissue development during postnatal fracture repair is influenced by the degree of 
mechanical stability at the fracture site.  Rigid stabilization supports direct new bone 
formation, while fixation that allows moderate interfragmentary movement in the fracture 
site promotes cartilage formation prior to new bone formation [142, 143].  Mechanical 
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stimulation has also been shown to support cartilage development by postnatal progenitor 
populations.  Periosteal autografts that were placed free-floating into the knee joint were 
found to form cartilage to an increased degree with the application of continuous passive 
motion compared to grafts subjected to joint immobilization [185].   
Experimental in vitro evidence for mechanical loading influences on chondrogenesis 
is limited.  Constant static compression of mouse limb bud cultures in gel suspension 
resulted in enhanced gene expression of the chondrogenic markers type II collagen and 
aggrecan [20].  Cyclic compressive loading increased 35S-sulfate incorporation and 
matrix staining in chick limb bud suspension cultures, while static loading elicited no 
effect [19].  Dynamic fluid pressure, when applied at low levels, enhanced proteoglycan 
matrix staining and type II collagen accumulation in rabbit periosteal explants suspended 
in agarose [186].  A study with human MPCs cultured as scaffold-free pellets under 
conditions promoting chondrogenic differentiation found that the application of cyclic 
hydrostatic pressure early in the culture period resulted in increased proteoglycan and 
collagen contents at 2-4 weeks of culture [187].  While this study provided evidence that 
differentiating MPCs are able to sense mechanical signals in an in vitro setting, 
chondrogenic differentiation and tissue development in the pellet culture format has 
limited relevance for cartilage tissue engineering considerations.  Studies evaluating 
mechanical loading influences on MPCs in a 3-D culture system that is compatible with 
development of a tissue-engineered cartilage construct are needed.   
Mechanical loading could be beneficial to multiple stages of the in vitro development 
of tissue-engineered cartilage constructs, including MPC chondrogenic differentiation, 
matrix production by differentiating and maturing cultures, and long-term tissue growth.  
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This chapter describes the evaluation of oscillatory compressive loading effects on the 
chondrogenic activity of MPC cultures suspended in alginate, where chondrogenic 
activity is an indicator of matrix production by differentiating cultures.  The effects of 
oscillatory mechanical stimulation on differentiating MPC cultures were evaluated by 
assessing the chondrogenic activity following application of daily 3 hour loading periods 
for 3 consecutive days.  Since the duration of exposure to chondrogenic media preceding 
loading initiation could modulate the MPC response to mechanical loading, oscillatory 
unconfined compressive loading was initiated following a variable preculture period of 1 
to 21 days in media containing TGF-β1, a supplement demonstrated to support MPC 
chondrogenic differentiation.  It was hypothesized that dynamic compressive loading in 
combination with chondrogenic supplements would enhance the chondrogenic activity of 
MPCs relative to the influence of supplements alone in a preculture time-dependent 
manner.  Proteoglycan synthesis, measured as the 35S-sulfate incorporation rate, and 
proteoglycan accumulation, measured as sulfated glycosaminoglycan (sGAG) 
accumulation, were utilized to assess MPC chondrogenic activity and were supported by 
the detection of type II collagen expression.  Protein synthesis, measured as the 3H-
proline incorporation rate, and DNA content were also evaluated as general culture 
markers.   
Methods 
Materials 
Goat MPCs were provided by Osiris Therapeutics, Baltimore, MD.  Bovine stifle joints 
were from Research 87, Marlborough. MA.  All media, trypsin, PBS, culture additives 
(unless noted otherwise), and pepsin were from Invitrogen Life Technologies, Chicago, 
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IL.  FBS was from Hyclone, Logan, UT.  Ascorbic acid-2-phosphate, L-proline, agarose, 
papain, DMMB, chondroitin sulfate A, and buffer reagents for the biochemical analyses 
were from Sigma-Aldrich, St. Louis, MO.  Agarase was from Calbiochem, EMD 
Biosciences, San Diego, CA.  ITS+ premix was from BD Biosciences, Bedford, MA.  
Recombinant human TGF-β1 and recombinant human FGF basic were from R&D 
Systems, Minneapolis, MN.  Pronova UP LVG alginate was from NovaMatrix, FMC 
BioPolymer, Norway.  Type II collagenase was from Worthington Biochemicals, 
Lakewood, NJ.  L-5-3H-proline was from Amersham Biosciences, Piscataway, NJ.  35S-
sodium sulfate and Ecolume were from MP Biomedical, Irvine, CA.  The PicoGreen kit 
was from Molecular Probes, Eugene, OR.  Immunohistochemistry reagents were from 
Vector Labs, Burlingame, CA.  
MPC Isolation and Expansion  
Osiris Therapeutics conducted the goat MPC isolation from iliac crest bone marrow 
aspirates followed by adherent primary expansion as described in their published 
methods for human MPCs [38].  Following primary culture, the cells were expanded for 
two passages (plating density 2700cells/cm2) in low glucose DMEM with 110mg/L 
sodium pyruvate and 584ml/L glutamine containing 10% FBS, 1% antibiotic/antimycotic 
(100units/ml penicillin, 100μg/ml streptomycin, 0.25μg/ml amphotericinB), and 1ng/ml 
FGF-2.  When cells had reached a near-confluent density, the flasks were incubated with 
0.42g/L trypsin, 0.44mM EDTA·4Na in Ca2+-free, Mg2+-free PBS followed by rinsing in 




3-D MPC Culture 
Passage 2 MPCs were suspended in one part Ca2+-free, Mg2+-free PBS and mixed with 2 
parts 3% Pronova UP LVG alginate (prepared in Ca2+-free, Mg2+-free PBS and filter 
sterilized) to yield a cell suspension of 12.5x106cells/ml.  45μl of the cell/alginate 
suspension was transferred to individual 4mm diameter wells of a custom-designed 
casting mold.  The cellulose acetate membrane filter positioned beneath the wells was 
wet with the polymerization solution (102mM CaCl2, 10mM Hepes, 100mM NaCl) prior 
to addition of the cell suspension.  After ~25 minutes of incubation, polymerization 
solution was added to the top of the wells.  Cylindrical gels were removed from the wells 
after a total incubation of ~60 minutes and incubated in 150mM NaCl for ~40 minutes, 
followed by incubation in chondrogenic media excluding the ascorbic acid-2-phosphate 
and TGF-β1 (see below) for ~40 minutes.  In one experiment, agarose gels were also cast 
by combining an equal volume of cells in media with 4% agarose (type VII low-gelling 
agarose powder in Ca2+-free, Mg2+-free PBS; autoclaved to sterilize) to yield a 2% 
agarose solution containing 12.5x106cells/ml.  45μl of the cell/agarose suspension to the 
wells of the casting mold, with filter paper prewet with PBS positioned beneath.  The 
agarose cultures gelled upon cooling to room temperature in the culture hood and were 
subsequently extracted from the molds and rinsed similarly to the alginate gels.  All gels 
were transferred to 48-well plates and cultured throughout the study in chondrogenic 
media (unless noted otherwise): high glucose DMEM with 110mg/L sodium pyruvate 
and 584ml/L glutamine containing 1% ITS+ premix (6.25μg/ml insulin, 6.25μg/ml 
transferrin, 6.25ng/ml selenious acid, 1.25mg/ml bovine serum albumin, 5.35mg/ml 
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linoleic acid), 1% antibiotic-antimycotic, 40μg/ml L-proline, 50μg/ml ascorbic acid-2-
phosphate, and 10ng/ml TGF-β1.  Cultures received fresh media changes every 1-2 days.    
Compressive Loading 
For loading initiation following the designated preculture period, gels were sized to 
3mm thickness using a custom-designed sizing tool (Figure 8), transferred to bioreactors, 
and subjected to unconfined uniaxial compressive deformation within the confines of a 
standard tissue culture incubator (37ºC, 5%CO2).  The daily loading protocol consisted of 
applying a dynamic load (15±3% compression at 1 Hz; sinusoidal waveform) or a 15% 
static load (15% compression) for 3 hours, followed by a cessation of loading for 21 
hours. Control gels were subjected to 0% static load for 3 hours.  Gel cultures were 
subjected to 3 days of consecutive loading (or 6 days in selected experiments).  With 
completion of the final loading day, gels were transferred to free swelling culture.  Unless 
noted otherwise, MPC gels were grown in culture media containing TGF-β1 throughout 
the duration of each study.   
There were no previous reports of compressive loading of MPCs in alginate 
suspension that could be used to guide the selection of loading parameters.  Frequency, 
compression peak amplitude, and compression static offset levels were therefore based 
upon protocols utilized with MPCs and chondrocytes in agarose suspension [24, 99, 188, 
189].  The selection of the 3 hour loading interval was based on previous studies with 
MPCs and other prechondrogenic cultures, where dynamic loading was applied for 1 to 4 
hours per day for multiple consecutive days [19, 188, 190].   
For dynamic loading, gel disks were subjected to oscillatory uniaxial unconfined 
compression using a compression device developed previously for studies with 
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chondrocyte cultures [191].  The compression device consisted of bioreactor cassettes, 
the loading frame, a digital control unit, and a power supply (Figure 9).  Each 
polycarbonate bioreactor cassette had a base containing 8 individual cylindrical wells into 
which the gels were placed and had a top with a cylindrical, solid, stainless steel platen 
located above the position of each well.  The cassette base was fixed to the stationary 
base plate of the loading frame and two cassettes could be positioned onto opposite sides 
of the loading frame.  The position of the cassette top, and thus the amount of 
compressive deformation applied to the gels, was determined by the position of the upper 
plate of the loading frame to which the top was mounted, and this upper plate was 
capable of controlled, uniaxial motion.  A linear stepper motor was attached to the base 
plate of the loading frame.  The upper plate of the loading frame rode on the lead screw 
of the stepper motor and was stabilized by three vertical guide posts.  Lead screw rotation 
was thus was converted into vertical motion of the upper plate.  Lead screw rotation was 
confirmed with a rotary encoder.  Digital control was used to apply an oscillatory motion 
profile.  To approximate a sinusoidal waveform, the load cycle was discretized into a 
series of thirty step motions.   
For static loading, gel disks were subjected to a static uniaxial unconfined 
compression using a polycarbonate bioreactor (Figure 9), in which gel disks were 
contained in individual wells in the base of the reactor and the lid of the bioreactor had 
individual solid platens that were located above each well.  The position of the lid of the 
reactor, and thus the amount of compressive deformation applied to the gels, was 
determined by the height of machined spacer bars.  The spacer bars fit into aligned 
grooves in the base and lid of the bioreactor.  At the end of the 3-hour loading period, the 
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spacer bars were replaced by bars with a height of ~3.4mm (except for the initial G117 
loading experiment in which replacement bars with a height of ~3.0mm were used).  
Prior to loading initiation on consecutive loading days, the dynamic and static bioreactors 
were disassembled, gels were repositioned within the reactor wells, the bioreactors were 
reassembled, and all gels were fed fresh media.   
Experimental Design 
The effects of oscillatory compressive loading on MPC chondrogenic activity were 
explored in a series of three studies (Table 4).  At the designated harvest time in all 
studies, gels were either subjected to biochemical or histological analyses.  
Study 1: Time-Dependent Loading Effects on MPC Chondrogenic Activity 
Early differentiating cultures were the focus for exploring the interaction between the 
preculture period in chondrogenic media and the MPC response to oscillatory loading.  In 
the initial loading experiment, MPCs were cultured for 1, 4, or 7 days and then loading 
was applied for 3 consecutive days.  Gels were harvested after the final loading day or on 
day 14.  This experiment was conducted at separate times in two different donors.  A 
primary difference was observed between the responses of the two donors for the early 
(day 1-3) loading interval.  Further clarification of the influence of early loading on 
MPCs was needed, so a portion of the initial loading experiment was repeated.  MPCs 
were cultured for 1 day, loading was applied for 3 consecutive days, and gels were 
harvested on day 14.  To more thoroughly evaluate the potential donor influence on the 




Study 2: Secondary Influences on the MPC Response to Dynamic Loading 
Given the limited responsiveness of MPC cultures to oscillatory loading in the initial 
loading study, a second study was conducted to evaluate the contribution of selected 
experimental variables on the MPC response to dynamic loading.  The study was divided 
into two experiments.  The first experiment evaluated the impact of both longer-term 
stimulation and TGF-β1 supplementation in a single MPC donor.  Gels were initially 
cultured with TGF-β1 supplementation to initiate chondrogenic differentiation.  
Concurrent with loading initiation on day 4, half of the gels were cultured in media 
lacking TGF-β1.  Loading was applied for 6 consecutive days, rather than 3 days as used 
in previous experiments, and gels were harvested on day 14.  The second experiment 
focused on the hydrogel material utilized in culturing the MPCs and compared 
compressive loading of MPCs in alginate and agarose gels for a single MPC donor.  
Loading was initiated on day 1 for 3 consecutive days and cultures were harvested on day 
14.     
Study 3: Comparing Loading Effects on MPC Chondrogenic Activity for Intermediate 
and Extended Preculture Times 
 
The previous loading studies focused on differentiating MPC cultures and indicated a 
lack of modulation of chondrogenic activity in response to oscillatory compressive 
loading.  However, a differentiated MPC culture with substantial matrix accumulation 
could have a different sensitivity to oscillatory loading effects on chondrogenic activity 
than the differentiating MPC cultures.  A study was conducted to explore this issue.  
Loading effects on MPC chondrogenic activity were compared for loading initiated at 
day 7, an intermediate preculture time corresponding to a differentiating MPC culture, 
and for loading initiated at day 21, an extended preculture time corresponding to a 
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differentiated MPC culture.  Loading was applied for 6 consecutive days and gels were 
harvested after the final loading day (1 donor; 1 experiment).  Concurrent with loading 
initiation, half of the MPC gels were cultured in media lacking TGF-β1 to assess possible 
interactions between loading and TGF-β1 supplementation.   
Radiolabel Incorporation  
At harvest, samples for biochemical analyses (n=4-6) were transferred to 96 well plates 
and incubated for 20 hours in 0.5ml culture media additionally containing 20 μCi/ml L-5-
3H-proline and 10 μCi/ml 35S-sodium sulfate.  At the end of the incubation period, the 
samples were transferred to new culture wells containing 1 ml of radiolabel quench 
solution, which was PBS additionally containing 0.8mM sodium sulfate and 1.0mM L-
proline.  Samples were washed in a total of four fresh aliquots of quench solution for ~30 
minutes per wash.  Samples were then transferred to preweighed tubes, weighed, and 
stored at -20ºC until further processing.  
Biochemical Analyses 
Alginate gels were lyophilized, weighed, resuspended in papain digest solution (150mM 
sodium phosphate dibasic, 5mM Na2EDTA, 5mM n-acetyl-L-cysteine pH 6.5 containing 
~1.7 units papain per sample), and incubated at 60ºC for 24 hours.  Agarose gel digestion 
involved a multi-step process.  Lypophilized samples were weighed, resuspended in the 
base digest buffer, heated to 70ºC for 30 minutes, cooled to 40ºC, incubated for two 
hours after receiving a concentrated agarase solution (final concentration ~5 mUnits per 
sample), and then incubated overnight at 60º after receiving a concentrated papain 
solution (final concentration ~1.7 units per sample).  For radiolabel incorporation 
measurements, 100μl of the sample digest was added to 2 ml Ecolume in a scintillation 
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vial.  Raw counts in CPM were obtained for each sample using a liquid scintillation 
counter.  3H and 35S activity were calculated from the raw counts based upon standard 
curves prepared from serial dilutions of the original radiolabeled media.  The activities 
were then converted into 3H-proline and 35S-sulfate incorporation rates.  Double-stranded 
DNA content was determined using the PicoGreen assay and quantified against a lambda 
DNA standard curve.  A 1:20 sample dilution was prepared in base buffer.  100μl sample 
dilution was mixed with 100μl PicoGreen reagent (prepared in 1X TE buffer according to 
the vendor instructions).  The mixture was incubated for 10 minutes and then measured 
on a Perkin-Elmer HTS 7000plus plate reader (excitation at 485nm; emission at 535nm).  
sGAG content was determined using a modified DMMB assay appropriate for use with 
alginate-containing samples [159].  sGAG content in experimental samples was 
quantified against a chondroitin-4-sulfate standard from bovine cartilage.  Alginate, at a 
concentration matching that in the sample dilutions, was included in the buffer used to 
create the chondroitin-4-sulfate standard curve to account for any interaction between the 
dye and alginate.  Sample dilutions were prepared as necessary in the appropriate base 
digest buffer.  200μl dye (~21mg/L dye in 29mM sodium formate, pH 1.5 adjusted with 
formic acid) was added to 20μl sample dilution in a 96 well plate and then measured 
immediately at 525nm on a Bio-Tek PowerWave X340 plate reader. 
Histological Analyses 
At harvest, samples were halved (n=1-2).  Gel halves were rinsed in PBS, soaked in 
100mM BaCl2 for ~45 minutes (alginate gels only), rinsed in PBS, transferred to 10% 
neutral-buffered formalin for 36-48 hours, rinsed in PBS and stored in 70% alcohol. 
Samples were subsequently embedded in paraffin and sectioned at five microns for 
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analysis.  Immunohistochemical assays were performed (see Appendix B for protocol) 
with a monoclonal antibody provided by the Developmental Studies Hybridoma Bank for 
Type II collagen (IgG II-II6B3).  Following deparaffinization and rehydration, tissue 
sections were incubated in pepsin 2 x 10 minutes.  Presence of the antigen was detected 
as an alkaline phosphatase deposit.  To control for nonspecific staining, one slide per 
batch was incubated with blocking serum rather than the primary antibody and then 
processed identically with the other slides.  Positive and negative control slides were also 
included.     
Statistical Analyses 
Data were analyzed using a general linear ANOVA model with Tukey’s test for post-hoc 
analysis (significance at p<0.05), where the effect of loading group on the biochemical 
parameter of interest was evaluated for a given MPC donor in each study.  Depending on 
the study, the effect of loading group was evaluated with respect to the designated 
loading interval and harvest time, the designated gel material, or the designated media 
condition.  While the data were presented normalized to the 15% static control group for 
each experiment, the raw data were used for statistical analyses. 
Results 
Time-Dependent Loading Effects on MPC Chondrogenic Activity 
Based upon an MPC time course study conducted previously that demonstrated the 
appearance of cartilage matrix components by culture day 7 in response to TGF-β1 
supplementation, the loading experiments were initiated during the first week of culture 
to focus on the earliest differentiating cultures.  Culture days 1, 4, and 7 were used for 
loading initiation and loading was applied for a 3-day interval, thereby enabling 
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comparisons between differentiating MPC cultures that exhibited different levels of 
matrix production at the time that loading was initiated.  In the initial loading experiment 
two culture endpoints were selected to allow the evaluation of both early (day after 
loading completion) and sustained (day 14) loading effects.  The experiment was 
conducted first in donor G117 and then was repeated at a separate time in donor G115.  
In the G117 cultures the loaded day 4-6 samples were significantly damaged due to an 
uncontrolled movement of the loading frame, and it was therefore not possible to include 
these samples in the endpoint analyses.       
For donor G117, the influence of dynamic loading depended on the timing of loading 
initiation (Figure 10, Figure 11).  For loading initiated on day 1, there were no early 
loading effects.  All loading groups were comparable at Day 4 for the parameters 
measured.  However, with additional culture to day 14, chondrogenic activity of the 
MPCs was modulated by dynamic loading.  The dynamic group had mean values for 35S-
sulfate incorporation (25% decrease versus 15% static group; 22% decrease versus 0% 
static group; p<0.001) and sGAG/DNA (27% decrease versus 15% static group; 23% 
decrease versus 0% static group; p<0.001) significantly lower than the static groups.  In 
the day 14 gels, fewer cells stained for type II collagen in the dynamically loaded cultures 
as compared to the statically loaded cultures (Figure 12).  At day 14, the dynamic group 
also had significantly lower DNA (29% decrease versus 15% static group; 21% decrease 
versus 0% static group; p<0.01) and significantly higher 3H-proline incorporation (27% 
increase versus 15% static group; 16% increase versus 0% static group; p<0.05) 
compared to the static groups following loading from day 1-3.  It should be noted that a 
deviation from the standard loading protocol occurred with the loaded day 1-3 samples.  
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The dynamically loaded gels were held under static compression during the 21 hour rest 
period on the first day of loading.  On the two subsequent loading days, the loading 
platens were held at a vertical position greater than the height of the gels, comparable to 
what was done in all other loading intervals in the G117 experiment and in all future 
experiments.   
For loading initiated on day 7 in the G117 cultures, chondrogenic activity was found 
to be comparable in all loading groups for each of the evaluation times (Figure 10, Figure 
11; Type II collagen staining not shown).  However, one notable transient effect of 
dynamic loading was detected.  In day 10 cultures the dynamic group had significantly 
higher 35S-sulfate incorporation compared to the static groups (13% increase versus 15% 
static group; 16% increase versus 0% static group; p<0.005), but in day 14 cultures 35S-
sulfate incorporation was comparable across all loading groups.  The increase in 35S-
sulfate incorporation at day 10 was not associated with enhanced sGAG/DNA in the 
dynamic group as compared to the static groups at either day 10 or day 14.  At day 10 the 
dynamic group also had significantly lower DNA content compared to the 0% static 
group (11%; p<0.01), but no other differences in DNA were observed at either time.  3H-
proline incorporation was comparable across all loading groups at days 10 and 14.  
Furthermore, the two static groups were comparable for all parameters measured for each 
loading interval and harvest time evaluated.   
For donor G115, dynamic loading did not modulate the chondrogenic activity of the 
MPC cultures for any of the three loading initiation times.  For each loading interval and 
harvest time evaluated, all loading groups were comparable for 35S-sulfate incorporation, 
sGAG/DNA, and Type II collagen staining, as well as DNA content and 3H-proline 
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incorporation, with one exception (Figure 13; Type II collagen staining not shown; DNA 
data not shown).  For the day 4-6 loading interval, the dynamic group exhibited a 
decrease in both 35S-sulfate incorporation (12%; p<0.05) and 3H-proline incorporation 
(12%; p<0.005) compared to the 15% static group at day 7, but there were no differences 
between the dynamic group and the 0% static group at day 7 or between the dynamic and 
static groups at day 14 for either incorporation measurement.    
In comparing the response of the two donors, a major difference was noted for the 
loaded day 1-3 set.  Dynamic loading resulted in a decrease in the chondrogenic activity 
of day 14 cultures for donor G117 but did not alter the chondrogenic activity of donor 
G115 cultures.  This difference could reflect a donor-dependent sensitivity to early 
dynamic loading or could be due to the differences in the loading protocols used with the 
two donors for the early loading period.  The two donors both showed no change in 
chondrogenic activity with dynamic loading for the loaded day 7-9 set, although one 
minor difference was noted at the early harvest time.  The stimulation of 35S-sulfate 
incorporation in the day 10 cultures for donor G117 but not donor G115 could be related 
to underlying differences in proteoglycan synthesis for the two donors.  At day 7, the two 
donors had comparable 35S-sulfate incorporation rates, but by day 10 donor G115 had a 
higher 35S-sulfate incorporation rate resulting from an increase in the rate for donor G115 
and to no change in the rate for donor G117 (data not shown). 
Further experimentation was needed to clarify the apparent discrepancy between 
donors in response to early dynamic loading.  The day 1-3 loading set of the initial 
loading experiment was subsequently repeated, with evaluation of the chondrogenic 
activity of day 14 cultures.  To more thoroughly explore the potential donor influence on 
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the response to early loading, a total of four donors were evaluated in parallel, including 
donors G117 and G115.  Dynamic loading did not modulate chondrogenic activity, as 
35S-sulfate incorporation, sGAG/DNA, and type II collagen staining were comparable 
across the loading groups for each donor evaluated (Figure 14, Figure 15).  DNA content 
and 3H-proline incorporation were also comparable across the loading groups for each 
donor with one exception.  For donor G132 the dynamic group exhibited a modest 
decrease in DNA compared to the 15% static group but not compared to the 0% static 
group (11%; p<0.035).  For each donor, the 0% static group was comparable to both the 
dynamic group and the 15% static group for the parameters measured (0% static data not 
shown).  Comparing the response for donor G117 in this experiment and in the initial 
experiment, it is concluded that the results for the loaded day 1-3 set in the initial 
experiment were due to the deviation in the loading protocol.  Together, the first two 
loading experiments demonstrated that oscillatory compressive loading initiated during 
the first week of culture did not alter the chondrogenic activity of differentiating MPC 
cultures and the lack of response to dynamic loading was consistent across multiple 
donors. 
Secondary Influences on the MPC Response to Dynamic Loading  
 A number of factors associated with the loading protocol could influence the ability 
of the MPCs to exhibit a response to oscillatory compressive loading.  In considering the 
loading protocol, a primary variable was the number of consecutive days that loading was 
applied.  Increasing the number of days that loading was applied could support a more 
slow-acting, cumulative loading effect on MPC chondrogenic activity that would not be 
possible with the 3-day loading interval used in the initial study.  Furthermore, TGF-β1 in 
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the culture media during loading could promote MPC chondrogenic activity at such a 
high level that its presence might mask any weaker stimulatory effects of dynamic 
loading.  An experiment was therefore conducted to assess the influences of longer-term 
loading and TGF-β1 supplementation on the response to dynamic loading.  Loading was 
initiated on day 4 and applied for 6 consecutive days.  Dynamic loading did not change 
the chondrogenic activity of day 14 MPC cultures (Table 5), in agreement with previous 
results for the day 4-6 loading interval.  The lack of response to dynamic loading was 
observed for loading in either the presence or absence of TGF-β1.  For each media 
formulation, all loading groups were comparable for 35S-sulfate incorporation and 
sGAG/DNA, as well as DNA content and 3H-proline incorporation.  
 In addition to the loading protocol, the culture system could also contribute to how 
MPCs respond to oscillatory compressive loading.  In considering the culture system, a 
primary variable was the hydrogel utilized in culturing the MPCs.  Agarose was a 
possible alternative hydrogel for these experiments, as it had been used in loading studies 
with chondroprogenitor cells and isolated chondrocytes [15, 19].  An experiment was 
conducted to compare the response to early loading (day 1-3) for MPCs suspended in 
alginate and agarose, with cultures evaluated at day 14.  In both alginate and agarose gels, 
dynamic loading did not modulate the response of the MPC cultures compared to the 
static groups for either 35S-sulfate incorporation or sGAG/DNA, indicators of 
chondrogenic activity (Table 6).  For agarose cultures, all loading groups were also 
comparable for DNA content and 3H-proline incorporation.  For alginate cultures, the 
dynamic group had significantly higher 3H-proline incorporation compared to the 15% 
static group (12%; p<0.02) and had significantly lower DNA content compared to the 
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15% static group (10%; p<0.03), but there were no differences between the dynamic 
group and the 0% static group for these parameters.  For each gel type, the two static 
groups were comparable for all parameters measured.     
Comparing Loading Effects on MPC Chondrogenic Activity for Intermediate and 
Extended Preculture Times 
 
The previous loading studies focused on differentiating MPC cultures and 
demonstrated a lack of response to oscillatory loading.  However, a differentiated MPC 
culture with substantial matrix accumulation could have a different sensitivity to 
oscillatory loading effects on chondrogenic activity than the differentiating MPC 
cultures.  A study was conducted to explore this issue and compared loading effects on 
MPC chondrogenic activity for loading initiated at intermediate and extended preculture 
times.  Loading was applied for 6 consecutive days and gels were harvested the day after 
loading completion.  Concurrent with loading initiation, half of the MPC gels were 
cultured in media lacking TGF-β1.  Based upon an MPC time course study conducted 
previously, day 7 was selected for the intermediate culture time to represent a 
differentiating MPC culture with relatively limited matrix accumulation, while Day 21 
was selected for the extended preculture period to represent a differentiated MPC culture 
with increased matrix accumulation.  The previous results indicated that sGAG had 
begun to accumulate but type II collagen staining was limited at day 7, while enhanced 
sGAG accumulation and extensive type II collagen staining were present at day 21. 
Dynamic loading modulated biosynthetic markers to a limited degree in the MPC 
cultures (Figure 16).  For MPC cultures supplemented with TGF-β1, the dynamic Day 7-
12 group exhibited an increase in 35S-sulfate incorporation compared to each static group 
(19% versus 15% static group; 14% versus 0% static group; p<0.02) but there were no 
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differences in sGAG/DNA (data not shown).  Also, the dynamic Day 21-26 group 
exhibited a decrease in 3H-proline incorporation compared only to the 0% static group 
(14%; p<0.02).  For MPC cultures where TGF-β1 was removed with loading initiation, 
the dynamic Day 7-12 group exhibited an increase in 35S-sulfate incorporation compared 
only to the 15% static group (25%; p<0.03) but there were no differences in sGAG/DNA 
(data not shown).  Also, the dynamic group exhibited a decrease in 3H-proline 
incorporation compared to the static groups for Day 7-12 loading (20% decrease versus 
15% static group; 18% decrease versus 0% static group; p<0.05) and for Day 21-26 
loading (15% decrease versus 15% static group; 15% decrease versus 0% static group; 
p<0.005).  sGAG/DNA and DNA were not modulated by dynamic loading at either 
loading interval for the media conditions evaluated (data not shown).  For both media 
conditions and loading intervals, the two static groups were comparable for the 
parameters measured. 
Discussion 
Mechanical preconditioning has been proposed as a stimulatory factor for the in vitro 
development of tissue-engineered cartilage constructs.  While adult MPCs are a 
promising cell source for cartilage tissue engineering applications, little is known about 
the ability of mechanical signals to influence MPC chondrogenic differentiation and 
matrix accumulation.  Assessing whether mechanical signals can be used to promote 
matrix production in differentiating MPCs in an in vitro culture system has important 
implications for cartilage tissue engineering strategies.  This work evaluated oscillatory 
compressive loading effects on the chondrogenic activity of MPCs undergoing 
chondrogenic differentiation in alginate suspension, with chondrogenic activity 
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representing an assessment of cartilage matrix production focusing on proteoglycan 
synthesis and sGAG accumulation.     
Oscillatory unconfined compressive loading of MPC/alginate gels initiated during the 
first seven days of culture and combined with TGF-β1 supplementation did not enhance 
chondrogenic activity above the level supported by TGF-β1 alone.  The length of the 
preculture period preceding loading initiation did not affect the response to dynamic 
loading, as three distinct culture times were evaluated and dynamic loading did not alter 
subsequent chondrogenic activity in any of the cultures.  To assess whether loading 
effects would enhance chondrogenic activity in a manner that was beneficial to the 
development of MPC-based tissue engineered implants, the evaluation of chondrogenic 
activity focused on the production of cartilage typical matrix components rather than 
gene expression changes and the experimental design emphasized sustained loading 
effects rather than very early loading effects.  Identification of an MPC culture showing 
enhanced chondrogenic activity with loading would have been followed by additional 
studies evaluating gene expression of appropriate matrix proteins.  However, evaluation 
of changes in gene expression in response to loading in the absence of corresponding 
changes in matrix accumulation would have had limited usefulness and was therefore not 
pursued given the results of the initial loading experiments.   
Two recent studies focusing on chondrogenic differentiation have demonstrated 
stimulatory effects for dynamic loading of MPC cultures.  The application of oscillatory 
compressive loading (4 hours/day) during the first week of culture notably increased 
aggrecan, type II collagen, and type I collagen gene expression and increased sGAG and 
hydroxyproline content over unloaded controls in day 14 cultures of human MPCs seeded 
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in a hyaluronanester-gelatin composite and cultured with chondrogenic supplements 
[190].  Differences in experimental variables between this study and the work presented 
in this chapter, including the scaffold/gel material and the number of loading days, might 
explain in part the differences in results with regard to loading effects on sGAG 
accumulation.  Daily oscillatory compressive loading (4 hours/day) stimulated aggrecan 
and type II collagen gene expression over no-load controls in rabbit MPC/agarose 
constructs cultured in the absence of chondrogenic supplements [188].  Importantly, 
changes in gene expression might not correlate to similar changes in protein expression, 
so direct comparison of the rabbit MPC study to our goat MPC experiments is not 
possible.   
The experimental approach taken in this work focused on evaluating MPC 
chondrogenic activity in a culture system, as related to the scaffold material and culture 
media, which was relevant to potential cartilage tissue engineering strategies.  The use of 
TGF-β1 supplementation to support chondrogenic differentiation and to maintain 
chondrogenic cultures in a serum-free media was therefore central to this approach.  
Since previous experimentation had established the stimulatory effects of various growth 
factors, including TGF-β1, for MPC chondrogenic differentiation and sustained long-
term culture, in vitro cartilage tissue engineering strategies utilizing MPCs would likely 
depend first and foremost upon the simpler strategy of chemical stimulation rather than 
the more complicated strategy of mechanical stimulation.  Thus, for the loading results to 
be consequential with respect to possible in vitro tissue engineering strategies, the benefit 
of mechanical stimulation would need to be proven in the presence of TGF-β1 or some 
other appropriate chemical stimuli.  Evaluating loading effects in the presence of growth 
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factors would also be more representative of the complex environment present during in 
vivo tissue development or regeneration.   
There are conflicting reports in the literature on combining mechanical stimulation 
and growth factor supplementation to support MPC differentiation and matrix 
accumulation.  Human MPCs cultured in the presence of chondrogenic supplements 
responded positively to dynamic compression and dynamic hydrostatic pressure [187, 
190, 192], while rabbit MPCs cultured in the absence of TGF-β1 showed a much greater 
stimulatory response to dynamic compression than cells cultured in the presence of TGF-
β1 [188].  The differences between these studies may suggest possibly important species 
differences regarding the interaction of TGF-β1 supplementation and the MPC response 
to mechanical stimulation.  Overall, conducting loading experiments on MPC cultures 
that had received no exposure to TGF-β1 would have been irrelevant to the underlying 
motivations of this work.  However, the lack of effect of dynamic compression observed 
in this work could be due in part to the dose of TGF-β1 used in these experiments.  The 
chondrogenic activity of MPCs exposed to continuous 10ng/ml TGF-β1 supplementation 
could have been at a near-saturation level and unable to be further positively modulated 
by the applied mechanical signals.  However, our observation that cultures either exposed 
to or lacking TGF-β1 during loading exhibited a lack of modulation in chondrogenic 
activity in response to oscillatory loading initiated on day 4 may indicate that other 
variables in the experimental design had a greater impact on the loading results than did 
media supplementation.          
 Another possible explanation for the lack of effect of oscillatory compressive loading 
observed in this work is that the combination of loading mode, loading parameters, and 
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gel material utilized in these experiments provided insufficient mechanical stimulation of 
the MPCs.  Properties of the alginate gel, including mechanical and surface 
characteristics, will determine how the macroscopic unixial compressive deformation 
applied to the cylindrical gels is transferred to the cellular microenvironment.  
Importantly, suspended cells cannot specifically interact with the surrounding alginate 
[193].  Potential sources of mechanical stimulation resulting from compressive loading of 
early MPC/alginate cultures with limited matrix accumulation include matrix-
independent cell deformation and fluid pressurization.  Gross static compression of 
BAC/alginate gels resulted in cellular deformation and a change in the nuclear 
morphology [194].  A recent preliminary study with human MPCs in alginate showed 
enhanced aggrecan gene expression and type II collagen deposition with exposure to 
TGF-β1 and cyclic hydrostatic pressurization [192].  However, the levels of cellular 
deformation and fluid pressurization associated with dynamic compression at the peak 
amplitude of 3% utilized in these experiments may have been inadequate to activate 
signal transduction pathways within the isolated cells.   
 The demonstration that MPCs in alginate and agarose both showed a lack of response 
to oscillatory compressive loading initiated on culture day 1 suggests that the response of 
very early MPC cultures to compressive loading is not restricted to culture in alginate 
suspension but is more generally indicative of culture in hydrogels that do not support 
specific interactions with the suspended cells.  Specific interactions between MPCs and 
the 3-D gel or scaffold in which the cells reside may be a potentially important mediator 
of mechanotransduction in cultures where extracellular matrix accumulation is limited.  
In contrast to our work with alginate gels, oscillatory compressive loading of MPC-
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seeded hyaluronanester-gelatin composite scaffolds was reported to support sustained 
enhancement of matrix synthesis [190].  One approach for exploring possible limitations 
of the current alginate culture system would be to utilize a hydrogel that incorporates 
adhesion sequences, such as RGD-functionalized alginate or agarose with covalently 
immobilized adhesion peptides [195, 196]. 
Secondary to the studies focusing on differentiating MPC cultures, one study 
compared loading effects on MPC chondrogenic activity for loading initiated at 
intermediate (day 7) and extended (day 21) preculture times.  Oscillatory compressive 
loading influenced biosynthesis rates to a limited degree but did not support changes in 
matrix accumulation of the MPC cultures.  Oscillatory compression applied during the 
second week of culture increased proteoglycan synthesis, but this effect was absent for 
loading of MPCs during the fourth week of culture.  Pericellular matrix accumulation 
with increasing time in culture could have limited the ability of MPCs to respond to 
mechanical loading at the later culture time, as the pericellular matrix may shield the cells 
from deformation in alginate gels similar to observations in agarose cultures [197].  The 
modulation in proteoglycan synthesis did not correlate with enhanced sGAG/DNA 
accumulation in the day 13 cultures, which could indicate that the increase in 35S-sulfate 
incorporation observed after loading completion was not indicative of 35S-sulfate 
incorporation levels present throughout the loading period.  Alternatively, the level of 
increase noted in 35S-sulfate incorporation may have been insufficient to appreciably alter 
the level of sGAG/DNA accumulation.  Identifying an oscillatory compressive loading 
protocol that enhanced matrix deposition in primary articular chondrocyte cultures was 
found to be challenging in previous studies.  A long-term loading protocol notably 
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influenced the mechanical properties of the accumulating matrix in articular 
chondrocyte/agarose cultures, but enhancement of sGAG and hydroxyproline content was 
noted only after three weeks of loading [15].  A recent investigation of short-term loading 
effects found that utilization of an alternate-day loading period stimulated proteoglycan 
synthesis but inhibited protein synthesis in articular chondrocyte/agarose cultures in low-
serum media [99].   
The loading experiments in this chapter do not address the possibility that long-term 
development of tissue-engineered cartilage constructs utilizing MPCs could benefit from 
a sustained oscillatory compressive loading protocol applied on the order of several 
weeks.  Sustained loading could support improved matrix organization or could promote 
small changes in matrix production that, when summed over many days, could lead to 
enhanced matrix accumulation.  Our results indicate that no benefit with regard to matrix 
production would be gained by loading MPC/alginate gels during the first week of 
culture, but it is possible that loading during the earliest phase of matrix accumulation 
could have unexpected benefits if included in a multi-week loading protocol for long-
term tissue development.  Furthermore, differentiating MPC cultures may be able to 
respond to mechanical stimulation in discrete, transient ways that would not have been 
detected with the experimental protocol used in these loading experiments, since the 
response to loading was evaluated following an extended period after loading completion.   
In conclusion, oscillatory unconfined compressive loading of MPC/alginate cultures 
in chondrogenic media did not enhance the chondrogenic activity of differentiating MPCs 
above the level supported by chondrogenic media alone for loading applied 3 hours/day 
for three to six consecutive days.  The length of the preculture period preceding loading 
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initiation, ranging from one to seven days, did not alter the lack of effect for oscillatory 
loading.  Furthermore, extending the preculture period to three weeks and thereby 
supporting enhanced matrix accumulation prior to loading also did not support a 
modulation of chondrogenic activity with oscillatory compressive loading.  While further 
research is needed to fully assess the overall utility of a mechanical preconditioning 
strategy based upon oscillatory compressive loading of MPCs, our results suggest that the 
enhancement of matrix production in MPC/hydrogel cultures requires that loading be 
conducted for greater than one week when loading is initiated during the first, second or 






































Figure 8: Gel Sizing Tool. Top: A gel is placed on its side into a 4mm diameter groove, 
which has slits running perpendicular to the groove, and the gel is positioned against a 
razor blade that sits in the designated slit. Middle: A second razor blade is placed into the 
adjacent designated slit, which is situated 3mm away from the first razor blade. Bottom: 


































Figure 9: Loading System & Reactors for Chondrogenic Activity Experiments. Left: 
Compression device (i.e. dynamic loading system) used to apply controlled deformation 
to gels situated within the bioreactor cassette via stainless steel platens located on the 
bottom surface of the bioreactor lid.  The bioreactor lid is attached to the top plate of the 
loading frame. Vertical movement of this top plate results from lead screw rotation of a 












Table 4: Summary of Studies Evaluating Oscillatory Compressive Loading Effects 
on MPC Chondrogenic Activity. For study 1, cultures were evaluated either the day 
after loading completion or on day 14.  For study 2, cultures were evaluated on day 14.  
For study 3, media supplementation (± TGF-β1) was a secondary variable of interest and 
all cultures were evaluated the day after loading completion.   
 
 Experimental Variable Levels Evaluated Number of  
Loading Days 
Study 1 Day of Loading Initiation Day 1, Day 4, or Day 7 3 
Study 2 1) Media Supplementation 
2) Hydrogel Material 
± TGF-β1 
Alginate or Agarose 
6 
3 
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Figure 10: Evaluation of Chondrogenic Activity in Donor G117 Cultures Subjected 
to Three-Day Compressive Loading. Dynamically loaded gels (15 ± 3% compression; 1 
Hz) were compared to gels held at 15% static compression and gels held at 0% static 
compression with loading for 3 hours each day. Cultures were evaluated on the day 
following loading completion or on day 14. Values are mean ± SEM (n=6gels/loading 
group; 1 experiment).  ‡ denotes significantly different versus static groups for the 
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Figure 11: Evaluation of Donor G117 Cultures Subjected to Three-Day 
Compressive Loading. Dynamically loaded gels (15 ± 3% compression; 1 Hz) were 
compared to gels held at 15% static compression and gels held at 0% static compression 
with loading for 3 hours each day. Cultures were evaluated on the day following loading 
completion or on day 14. Values are mean ± SEM (n=6gels/loading group; 1 
experiment).  ‡ denotes significantly different versus static groups for the designated 




























Figure 12: Type II Collagen Staining of Day 14 G117 Cultures Loaded on Days 1-3. 
Type II collagen immunostaining (20X; red coloration indicates presence of antigen) of 
gels subjected to dynamic compression (15±3% compression at 1 Hz), 15% static 
compression, or 0% static compression for 3 hours/day for 3 consecutive days beginning 
on culture day 1 and then cultured to day 14.     
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Figure 13: Evaluation of Donor G115 Cultures Subjected to Three-Day 
Compressive Loading. Cultures (dynamically loaded at 1 Hz or statically loaded to 15% 
or 0% for 3hr/day) were evaluated on the day following loading or on day 14. (Mean ± 
SEM; n=6gels/loading group; 1 experiment).  * denotes significantly different vs. 15% 





























































































































Figure 14: Comparison of the MPC Donor Response to Compressive Loading for 
Cultures Loaded on Days 1-3. Dynamically loaded gels (15 ± 3% compression; 1 Hz) 
were compared to gels held at 15% static compression and gels held at 0% static 
compression with loading for 3 hours each day. Cultures were evaluated on day 14 for 
four MPC donors (donor G117, etc). Values are mean ± SEM (n=6gels/loading group; 1 
experiment). * denotes significantly different vs. 15% static for the designated donor. For 
each donor, the 0% static group was comparable to both the dynamic group and the 15% 



























Figure 15: Type II Collagen Staining of Day 14 MPC Cultures Loaded on Days 1-3. 
Type II collagen immunostaining (20X; red coloration indicates presence of antigen; 
images shown for donor G117) of gels subjected to dynamic compression (15±3% 
compression at 1 Hz), 15% static compression, or 0% static compression for 3 hours/day 
for 3 consecutive days beginning on culture day 1 and then cultured to day 14.     
Dynamic
15% Static                                                 0% Static 
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Table 5: Comparison of TGF-β1 Supplementation on the Response to Loading on 
Days 4-9. Gels were subjected to dynamic compression (15±3% compression at 1 Hz), 
15% static compression, or 0% static compression for 3 hours/day. Cultures were 
evaluated on day 14. TGF-β1 was either included in the culture media for the duration of 
the experiment (MPC+TGF-β1) or was excluded concurrent with loading initiation 







sGAG/DNA DNA 3H-Proline  
Incorporation 
 
MPC + TGF-β1 
    
Dynamic    1.006      
± 0.013 
  1.007      
± 0.023 
  0.975      
± 0.027 
   1.049      
± 0.026 
15% Static    1.000      
± 0.025 
  1.000      
± 0.028 
   1.000      
± 0.046 
   1.000      
± 0.054 
0% Static    1.049      
± 0.041 
  1.067      
± 0.045 
  1.014      
± 0.043 




    
Dynamic    0.992      
± 0.148 
  0.924      
± 0.084 
  0.989      
± 0.036 
   0.959      
± 0.118 
15% Static    1.000      
± 0.050 
  1.000      
± 0.039 
  1.000      
± 0.040 
   1.000      
± 0.035 
0% Static    1.060      
± 0.039 
  1.041      
± 0.036 
  0.981      
± 0.028 




Table 6: Comparison of Hydrogel Materials on the Response to Loading on Days 1-
3. MPCs were suspended in alginate or agarose, then gels were subjected to dynamic 
compression (15±3% compression at 1 Hz), 15% static compression, or 0% static 
compression for 3 hours/day. Cultures were evaluated on day 14. Values are mean ± 
SEM (n=6gels/loading group except n=4 for agarose dynamic; Donor G117; 1 












    
Dynamic    1.050      
± 0.019 
  1.060      
± 0.020 
* 0.899     
± 0.024 
 * 1.117       
± 0.027 
15% Static    1.000      
± 0.022 
   1.000      
± 0.021 
  1.000     
± 0.023 
   1.000       
± 0.015 
0% Static    1.025      
± 0.023 
  1.058      
± 0.035 
  0.954     
± 0.026 




    
Dynamic    0.739      
± 0.063 
  0.726      
± 0.113 
  0.971     
± 0.019 
   0.892       
± 0.047 
15% Static    1.000      
± 0.077 
  1.000      
± 0.091 
  1.000     
± 0.072 
   1.000       
± 0.030 
0% Static    0.917      
± 0.055 
  0.906      
± 0.102 
  0.904     
± 0.055 
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Figure 16: Comparison of Compressive Loading Effects for MPC Cultures at 
Intermediate and Extended Preculture Times. Gels were subjected to dynamic 
compression (15±3% compression at 1 Hz), 15% static compression, or 0% static 
compression for 3 hours per day for 6 consecutive days beginning on culture day 7 or day 
21. TGF-β1 was either included in the MPC culture media for the duration of the 
experiment (MPC+TGF) or was excluded concurrent with loading initiation (MPC). 
Values are mean ± SEM (n=6gels/loading group/cell type except n=4 for day 13 
dynamic; 1 experiment). ‡ denotes significantly different vs. static groups for the 
designated cell type. * denotes significantly different vs. 15% static for the designated 




CHAPTER 5  
EVALUATION OF MPC BIOSYNTHESIS DURING CONTINUOUS 
OSCILLATORY COMPRESSIVE LOADING 
 
Introduction 
Orthopaedic tissues, such as bone and cartilage, are subjected to frequent and 
repeated bouts of mechanical loading with normal activity.  Evaluations at the tissue level 
have shown that mechanical stimulation or the lack thereof can alter tissue composition.  
In bone, experimental models of disuse result in a loss of bone mineral density and 
exercise above normal activity levels may be beneficial for recovery of bone mineral 
density with remobilization [198, 199].  Likewise, experimental studies have indicated 
that exercise leads to increased proteoglycan content in articular cartilage, while joint 
immobilization leads to a loss of proteoglycan content that can be recovered with 
restoration of joint mobility [58].  
These changes in tissue composition are ultimately the result of changes in 
metabolism of individual cells.  To explore linkages between mechanical stimulation and 
changes in cellular activities, in vitro studies have been conducted on isolated cells 
cultured in a variety of systems.  Proteoglycan synthesis, type II collagen gene 
expression, and aggrecan gene expression have been shown to be modulated in isolated 
chondrocytes by various loading protocols evaluating compression and hydrostatic 
pressure [24, 61, 63, 66, 67].  Osteoblast proliferation, alkaline phosphatase activity, and 
osteopontin gene expression have been demonstrated to change in response to fluid flow 
and strain [200-204].      
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While much attention has focused on evaluating the response to mechanical 
stimulation in differentiated cells isolated from mature tissue, multipotential progenitor 
cells and lineage-committed progenitor cells will also be subjected to mechanical 
stimulation during orthopaedic tissue development and repair.  There is limited evidence 
to indicate that forms of mechanical loading shown to modulate differentiated cells may 
also influence responses in progenitor populations.  Rat bone marrow stromal cells 
showed enhancement of alkaline phosphatase expression with application of cyclic strain 
[205].  Human marrow stromal cells subjected to oscillatory fluid flow exhibited 
increased proliferation and increased osteopontin and osteocalcin mRNA levels [145].  
Increased gene expression for the chondrogenic markers aggrecan and type II collagen 
was observed with oscillatory compressive loading of rabbit mesenchymal stem cells 
[188].  A similar response was noted for hydrostatic pressurization of bovine bone 
marrow stromal cells [146].  Together these studies provide direct evidence that 
progenitor cells exhibit mechanoresponsiveness.  
Mesenchymal progenitor cells (MPCs) have been identified as a potential cell source 
for orthopaedic tissue engineering strategies.  Given the mechanically complex 
environment into which these cells may be placed, understanding how MPCs, both as 
undifferentiated and differentiating populations, respond to mechanical stimulation is 
important.  Determining how MPCs respond to types of loading known to modulate the 
response of differentiated cells is one area of necessary investigation.  The primary focus 
of this chapter was to evaluate MPC biosynthesis during continuous oscillatory 
compressive loading of MPC/alginate cultures.  The mechanoresponsiveness of MPCs 
undergoing chondrogenic differentiation was evaluated for a loading protocol shown 
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previously to enhance biosynthesis of chondrocytes in hydrogel suspension [24].  Our 
hypothesis was that oscillatory compressive mechanical loading would stimulate 
proteoglycan and protein synthesis in differentiating MPC cultures, but would not 
modulate biosynthesis in prechondrogenic MPC cultures.  Oscillatory unconfined 
compressive loading was applied continuously for a single 20 hour period to gels that 
were being cultured in media containing radiolabeled sulfate (for proteoglycan synthesis) 
and proline (for protein synthesis) compounds.  For all groups, the effects of loading were 
determined by comparing radiolabel incorporation rates in dynamically loaded constructs 
to static control constructs.  MPCs were cultured in media containing TGF-β1 to support 
chondrogenic differentiation.  Loading was initiated at culture times (days 1, 4, and 7) 
demonstrated in Aims 1 and 2 to correspond to distinct MPC cultures, as distinguished by 
increasing levels of proteoglycan synthesis and sGAG accumulation with increasing time 
in culture.       
No previous reports were available for radiolabel-oscillatory compression studies 
utilizing alginate suspension of isolated chondrocytes at early cultures times.  Therefore, 
bovine articular chondrocytes (BACs) were also subjected to the described loading 
protocol to provide a baseline assessment of primary articular chondrocyte 
mechanoresponsiveness in alginate suspension.  A primary goal of the initial loading 
study was to identify a loading protocol that would stimulate proteoglycan synthesis in 
day 1 BAC/alginate cultures, similar to previous results in BAC/agarose cultures.  The 
loading frequency level was found to be a critical parameter influencing 




Goat MPCs were provided by Osiris Therapeutics, Baltimore, MD.  Bovine stifle joints 
were from Research 87, Marlborough. MA.  All media, trypsin, PBS, culture additives 
(unless noted otherwise), and pepsin were from Invitrogen Life Technologies, Chicago, 
IL.  FBS was from JRH Biosciences, CA, for the MPC cultures and was from Hyclone, 
Logan, UT, for the BAC cultures.  Ascorbic acid-2-phosphate, L-proline, papain, 
DMMB, chondroitin sulfate A, and buffer reagents for the biochemical analyses were 
from Sigma-Aldrich, St. Louis, MO.  ITS+ premix was from BD Biosciences, Bedford, 
MA.  Recombinant human TGF-β1 and recombinant human FGF basic were from R&D 
Systems, Minneapolis, MN.  Pronova UP LVG alginate was from NovaMatrix, FMC 
BioPolymer, Norway.  Type II collagenase was from Worthington Biochemicals, 
Lakewood, NJ.  L-5-3H-proline was from Amersham Biosciences, Piscataway, NJ.  35S-
sodium sulfate and Ecolume were from MP Biomedical, Irvine, CA.  The PicoGreen kit 
was from Molecular Probes, Eugene, OR.   
MPC Isolation and Expansion  
Osiris Therapeutics conducted the goat MPC isolation from iliac crest bone marrow 
aspirates followed by adherent primary expansion as described in their published 
methods for human MPCs [38].  At a later time, passage 0 MPCs were thawed, expanded 
for one passage, and then the passage 1 MPCs were cryopreserved.  To initiate each 
loading experiment, passage 1 MPCs were thawed and expanded for one additional 
passage before being cast into alginate gels.  Expansion from passage 0 to passage 2 
(2700cells/cm2 seeding density) was conducted in low glucose DMEM with 110mg/L 
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sodium pyruvate and 584ml/L glutamine containing 10% FBS, 1% antibiotic-antimycotic 
(100units/ml penicillin, 100μg/ml streptomycin, 0.25μg/ml amphotericinB), and 1ng/ml 
FGF-2.  When cells had reached a near-confluent density, the flasks were incubated with 
0.42g/L trypsin, 0.44mM EDTA·4Na in Ca2+-free, Mg2+-free PBS followed by rinsing in 
standard expansion media to release the cells.  
3-D MPC Culture 
Passage 2 MPCs were suspended in one part Ca2+-free, Mg2+-free PBS and mixed with 2 
parts 3% Pronova UP LVG alginate (prepared in Ca2+-free, Mg2+-free PBS and filter 
sterilized) to yield a cell suspension of 12.5x106cells/ml.  45μl of the cell/alginate 
suspension was transferred to individual 4mm diameter wells of a custom-designed 
casting mold.  The casting mold consisted of four pieces (from bottom to top): solid 
polycarbonate base, wire mesh, grade #2 Whatman filter paper, and top polycarbonate 
piece with a 4x4 grid of 4mm diameter holes drilled out.  The filter paper was prewet 
with the polymerization solution (102mM CaCl2, 10mM Hepes, 100mM NaCl) prior to 
addition of the cell suspension.  After ~25 minutes of incubation, polymerization solution 
was added to the top of the wells.  Cylindrical gels were removed from the wells after a 
total incubation of ~60 minutes and incubated in 150mM NaCl for ~40 minutes, followed 
by incubation in chondrogenic media (see below) excluding the ascorbic acid-2-
phosphate and TGF-β1 for ~40 minutes.  Gels were then transferred to 48-well plates 
and, unless noted otherwise, cultured throughout the study in chondrogenic media: high 
glucose DMEM with 110mg/L sodium pyruvate and 584ml/L glutamine containing 1% 
ITS+ premix (6.25μg/ml insulin, 6.25μg/ml transferrin, 6.25ng/ml selenious acid, 
1.25mg/ml bovine serum albumin, 5.35mg/ml linoleic acid), 1% antibiotic-antimycotic, 
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40μg/ml L-proline, 50μg/ml ascorbic acid-2-phosphate, and 10ng/ml TGF-β1. Cultures 
received fresh media changes every 1-2 days.    
BAC Isolation and 3-D Culture 
BACs were cultured in parallel with the goat MPCs for comparison.  The BACs were 
isolated from femoral cartilage (patellar groove and condyles) of immature calves (~2-4 
weeks old) by type II collagenase digestion (520units/ml in high glucose DMEM with 
5ml/L neomycin, 10ml/L kanamycin, and 10ml/L antibiotic-antimycotic) for ~42 hours.  
The isolated chondrocytes were combined with 90% FBS and 10% DMSO, transferred to 
cryovials, placed in a controlled freezing container, and after ~2 days at -80ºC transferred 
to LiN2 storage.  Thawed BACs were seeded in 2% alginate at 12.5x106cells/ml as 
described above for MPCs. The BAC-alginate constructs were cultured in high glucose 
DMEM containing 10% FBS, 1% antibiotic-antimycotic, 40μg/ml L-proline, and 
50μg/ml ascorbic acid-2-phosphate.  Cultures received fresh media changes every 1-2 
days.  BAC cultures were grown in serum-containing media to match previous 
radiolabel-oscillatory compression studies with BACs in hydrogel suspension [24, 62].    
Compressive Loading and Radiolabel 
For loading initiation following the designated preculture period, gels were sized to 
3mm thickness using a custom-designed sizing tool (Figure 8), transferred to bioreactors, 
fed with standard culture media (described previously for each cell type) additionally 
supplemented with 20 μCi/ml L-5-3H-proline and 10 μCi/ml 35S-sodium sulfate, and 
subjected to 20 hours of unconfined compressive deformation (15±3% compression at a 
frequency ranging from 0.1-1.0 Hz as specified for each experiment).  Control gels were 
transferred to comparable bioreactors, fed with media containing radiolabel, and 
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subjected to 20 hours continuous unconfined static deformation (15% compression).  At 
the end of the 20 hour loading period, gels were transferred to 48-well plates containing 1 
ml of radiolabel quench solution (PBS additionally containing 0.8mM Na2SO4 and 
1.0mM L-proline) per well.  Samples were washed in a total of four fresh aliquots of 
quench solution for ~30 minutes per wash. Samples were then transferred to preweighed 
tubes, weighed, and stored at -20ºC until further processing.   
There were no previous reports of compressive loading of MPC/alginate or early 
BAC/alginate cultures that could be used to guide the selection of loading parameters.  
Compression peak amplitude, compression static offset, and duration of the load-
radiolabel period were based upon protocols with BAC/agarose cultures and with mature 
BAC/alginate cultures [24, 41, 62, 189].    
For dynamic loading, gel disks were subjected to oscillatory uniaxial unconfined 
compression using a compression device recently developed by our collaborators for 
loading studies with various tissue explants and cell-seeded constructs.  The compression 
device consisted of bioreactor cassettes, the loading frame, a digital control unit, and a 
power supply (Figure 17).  Each polysulfone bioreactor cassette had a base containing 8 
individual cylindrical wells into which the gels were placed and had a top with a 
cylindrical, solid, stainless steel platen located above the position of each well.  The 
cassettes were slid into a central shallow groove in the stationary base plate of the loading 
frame, and a total of four cassettes could be accommodated in the loading frame.  The 
position of each cassette top, and thus the amount of compressive deformation applied to 
the gels, was determined by the position of the upper plate of the loading frame to which 
each top was mounted, and this upper plate was capable of controlled, uniaxial motion.  
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A square rail linear table was attached to the base plate of the loading frame.  The servo 
motor was driven by a servo drive.  The upper plate of the loading frame was bracketed 
to the front face of the linear table.  Vertical motion was confirmed with a linear encoder 
affixed external to the linear table.  Programming software was used to apply a sinusoidal 
motion profile at the specified frequency.         
For static loading, gel disks were subjected to a static uniaxial unconfined 
compression using the same polysulfone reactors used for dynamic loading or using a 
polycarbonate bioreactor (described previously in Chapter 4 methods).  For each type of 
reactor, the position of the lid of the reactor, and thus the amount of compressive 
deformation applied to the gels, was determined by the height of machined spacer bars.  
The spacer bars fit into aligned grooves in the base and lid of the bioreactor.  Preliminary 
testing verified that both MPC and BAC cultures held at 15% static compression for 20 
hours had 3H-proline and 35S-sulfate incorporation rates comparable to cultures held at 
0% static compression (data not shown), consistent with a study demonstrating no 
response to static compression in early BAC/agarose cultures [24].     
Experimental Design 
A series of three studies was conducted to evaluate biosynthesis of MPC and BAC 
cultures with application of continuous oscillatory compressive loading (Table 7).   
Study 1: Preliminary Loading Frequency Comparison 
The goal of the initial study was to identify a loading frequency that would stimulate 
proteoglycan synthesis in day 1 BAC/alginate cultures.  A pair of experiments was 
conducted with day 1 BAC cultures in which two loading frequencies were evaluated in 
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each experiment (1.0 Hz and 0.33 Hz; 0.33 Hz and 0.1 Hz).  Due to limited donor cell 
numbers, different BAC donors were used in the two experiments.   
Study 2: Influences of Cell Type and Culture Time on Mechanoresponsiveness 
With completion of the first study, the 0.1 Hz loading frequency was selected as an 
appropriate loading frequency based upon the observed stimulation of proteoglycan 
synthesis in the day 1 BAC cultures.  Subsequently, a study was conducted at 0.1 Hz to 
evaluate biosynthesis of MPCs and BACs with oscillatory loading.  Loading with 
radiolabel was initiated on days 1, 4, and 7.  Two experiments were conducted at separate 
times.  The same MPC donor but different BAC donors were used in the two 
experiments.  Additionally, in the second loading experiment, media supplementation 
was an additional experimental variable evaluated for day 1 MPCs, with the response of 
MPCs cultured in the absence of TGF-β1 compared to the response of MPCs cultured in 
the standard chondrogenic media containing 10ng/ml TGF-β1. 
Study 3: Influence of Loading Frequency on Mechanoresponsiveness 
Based in part upon observations in the initial loading study, two experiments were 
conducted to further evaluate how varying the loading frequency would influence 
biosynthesis during oscillatory compressive loading.  Given the noted influence of 
loading frequency on day 1 BAC biosynthesis, it was of interest to determine whether 
altering the loading frequency would modulate day 1 MPC biosynthesis.  Therefore, an 
experiment was conducted to evaluate biosynthesis with oscillatory loading at higher 
frequencies (0.33 Hz and 1.0 Hz) and compared the response of day 1 MPC cultures 
supplemented with TGF-β1 to cultures lacking TGF-β1 supplementation (1 donor; 1 
experiment).  As the loading frequency was found to influence both day 1 BAC and MPC 
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biosynthesis, it was of interest to determine whether sensitivity to loading frequency was 
maintained with additional time in culture.  Therefore, an experiment was conducted to 
evaluate biosynthesis with oscillatory loading at higher frequencies (0.33 Hz and 1.0 Hz) 
for day 7 MPC and BAC cultures (1 donor per cell type; 1 experiment).   
Biochemical Analyses 
Gels were lyophilized, weighed, resuspended in papain digest solution (150mM sodium 
phosphate dibasic, 5mM Na2EDTA, 5mM n-acetyl-L-cysteine pH 6.5 containing ~1.7 
units papain per sample), and incubated at 60ºC for 24 hours.  For radiolabel 
incorporation measurements, 100μl of the sample digest was added to 2 ml Ecolume in a 
scintillation vial.  Raw counts in CPM were obtained for each sample using a liquid 
scintillation counter.  3H and 35S activity were calculated from the raw counts based upon 
standard curves prepared from serial dilutions of the original radiolabeled media.  The 
activities were then converted into 3H-proline and 35S-sulfate incorporation rates.  
Double-stranded DNA content was determined using the PicoGreen assay and quantified 
against a lambda DNA standard curve.  A 1:20 sample dilution was prepared in base 
buffer.  100μl sample dilution was mixed with 100μl PicoGreen reagent (prepared in 1X 
TE buffer according to the vendor instructions).  The mixture was incubated for 10 
minutes and then measured on a Perkin-Elmer HTS 7000plus plate reader (excitation at 
485nm; emission at 535nm).  For selected samples, sulfated glycosaminglycan (sGAG) 
content was determined using a modified DMMB assay appropriate for use with alginate-
containing samples [159].  sGAG content in experimental samples was quantified against 
a chondroitin-4-sulfate standard from bovine cartilage.  Alginate, at a concentration 
matching that in the sample dilutions, was included in the buffer used to create the 
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chondroitin-4-sulfate standard curve to account for any interaction between the dye and 
alginate.  Sample dilutions were prepared as necessary in the appropriate base digest 
buffer.  200μl dye (~21mg/L dye in 29mM sodium formate, pH 1.5 adjusted with formic 
acid) was added to 20μl sample dilution in a 96-well plate and then measured 
immediately at 525nm on a Bio-Tek PowerWave X340 plate reader. 
Mechanical Testing of Alginate Cultures 
To characterize the behavior of alginate cultures subjected to oscillatory compressive 
loading, mechanical testing was performed on MPC-seeded gel samples prepared and 
cultured identically to those used in loading experiments.  For each test, a gel sample was 
placed into a cylindrical sample holder, which was screwed directly into the top surface 
of a 1.1lbf load cell.  The load cell was affixed to the testing frame of the ELectroForce 
3200 testing system (EnduraTEC, Minnetonka, MN).  The sample holder was filled with 
ITS+-containing culture media.  A solid stainless steel platen was used to apply controlled 
deformation to the upper face of the gel sample, resulting in uniaxial, unconfined 
compression of the sample.  The testing protocol was designed to simulate dynamic 
loading conditions.  Initially, the sample was ramped to 10% compression, held for 30 
minutes to account for the time associated with loading set-up in an actual experiment, 
ramped further to 15% compression and then cyclic loading (±3% deformation at the 
specified loading frequency) was initiated.  Data were captured for the first 50 seconds of 
every 11 minutes for ~3.5 hours.  MPC-seeded alginate gels grown to culture days 1 and 
7 were evaluated.  For testing on culture day 1, samples were evaluated for all three 
loading frequencies used in the loading experiments (n=1-2/frequency).  For loading on 
day 7, samples were evaluated at frequencies of 0.1 and 1 Hz (n=2/frequency).  The 
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dynamic compressive modulus was estimated from the slope of the stress-strain curve 
corresponding to the tenth compression cycle ranging from 15% to 18% deformation for 
1 Hz loading on day 1.            
Statistical Analyses 
Data were analyzed using a general linear ANOVA model to evaluate the effect of load 
(or culture day in selected control, no-load analyses) on the biochemical parameter of 
interest for each cell type and culture day (significance at p<0.05), with Tukey’s test 
utilized for post-hoc analysis where appropriate.  For the pair of experiments conducted 
at 0.1 Hz, the ANOVA model included experiment and load for each cell type and culture 
day.  While the data were presented normalized to the 15% static control group for each 
experiment, the raw data were used for statistical analyses. 
Results 
Preliminary Loading Frequency Comparison 
A necessary step in the development of this aim was to identify a loading protocol 
that would be stimulatory for early BAC/alginate cultures, similar to reports in the 
literature for early BAC/agarose cultures.  Loading frequency was the initial loading 
parameter evaluated.  For the selected deformational protocol (15±3% compression), day 
1 BAC cultures were loaded at 3 frequency levels and the response to dynamic loading 
was found to be frequency-dependent (Figure 18).  Oscillatory loading at 1.0 Hz, the 
highest frequency evaluated, decreased both 35S-sulfate incorporation (16%; p=0.003) 
and 3H-proline incorporation (13%; p<0.05) compared to the 15% static group.  
Decreasing the loading frequency to 0.33 Hz led to a lack of response in the BAC 
cultures.  In each experiment, there were no differences in 35S-sulfate or 3H-proline 
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incorporation between oscillatory loading at 0.33 Hz and the 15% static group.  Further 
reducing the loading frequency to 0.1 Hz, the lowest frequency evaluated, led to a 
marked change in the response of the BAC cultures.  Oscillatory loading at 0.1 Hz 
increased both 35S-sulfate incorporation (17%; p=0.001) and 3H-proline incorporation 
(19%; p<0.001) compared to the 15% static group.  DNA content was comparable across 
all loading groups for each experiment conducted (data not shown).   
Influences of Cell Type and Culture Time on Mechanoresponsiveness 
With validation of a loading protocol that was stimulatory for day 1 BAC/alginate 
cultures, an oscillatory loading study was subsequently conducted at 0.1 Hz to assess 
changes in biosynthesis in MPC and BAC cultures upon application of loading at 
multiple times (days 1, 4, and 7) during the first week of culture.  There were notable 
differences in the response to oscillatory loading for the two cell types at the earlier 
culture times (Figure 19).  In BAC cultures, oscillatory loading increased 3H-proline 
incorporation compared to the 15% static group at day 1 (14%; p=0.001), day 4 (9%; 
p<0.005), and day 7 (7%; p<0.03) and also increased 35S-sulfate incorporation compared 
to the 15% static group at day 1 (8%; p<0.05) and day 4 (8%; p<0.01).   
In contrast to the BAC cultures, there were no differences in 35S-sulfate or 3H-proline 
incorporation between the oscillatory loading group and the 15% static group for MPC 
cultures at day 1 or day 4. However, with additional time in culture preceding loading 
initiation, the MPC cultures exhibited an alteration in biosynthesis with oscillatory 
loading.  In the day 7 MPC cultures, oscillatory loading increased both 3H-proline 
incorporation (6%; p<0.02) and 35S-sulfate incorporation (8%; p<0.01) compared to the 
15% static group.  No differences were found in DNA content between any of the loading 
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groups for each combination of cell type and culture time evaluated with the exception of 
day 1 MPC cultures, which were found to be inhibited with oscillatory loading compared 
to 15% static compression (5%; p=0.03; data not shown).  Additionally, the influence of 
media supplementation on the response to oscillatory loading was evaluated for day 1 
MPC cultures, with the response of MPCs cultured in the absence of TGF-β1 compared 
to the response of MPCs cultured in the standard chondrogenic media containing 10ng/ml 
TGF-β1.  No differences in 35S-sulfate or 3H-proline incorporation were noted between 
the oscillatory loading group and the 15% static group for either media formulation 
(Table 8).   
In evaluating the baseline activity of control MPC and BAC cultures, changes in 
biosynthesis and sGAG/DNA accumulation were observed during the first week of 
culture (Table 9).  35S-sulfate incorporation, 3H-proline incorporation, and sGAG/DNA 
all increased from day 1 to day 7 in the MPC cultures (p<0.001).  For the BAC cultures, 
sGAG/DNA increased from day 1 to day 7 (p<0.001), while 35S-sulfate incorporation and 
3H-proline incorporation initially increased from day 1 to day 4 (p<0.005), then 35S-
sulfate incorporation decreased to an intermediate value (p<0.001) but 3H-proline 
incorporation did not change from day 4 to day 7.   
Influence of Loading Frequency on Mechanoresponsiveness 
Observations from the initial loading study prompted further experimentation to 
evaluate how oscillatory loading at higher frequencies (0.33 Hz and 1.0 Hz) would 
influence biosynthesis during oscillatory compressive loading.  Given the noted influence 
of loading frequency on day 1 BAC biosynthesis, an experiment was conducted to 
determine whether day 1 MPCs also exhibited sensitivity to loading frequency.  In this 
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experiment, the response of MPC cultures supplemented with TGF-β1 was compared to 
the response of cultures lacking TGF-β1 supplementation.  There were no differences in 
35S-sulfate or 3H-proline incorporation between the oscillatory loading groups at the two 
loading frequencies evaluated and the 15% static group for either media formulation, 
with one noted exception (Table 10).  Oscillatory loading at 1.0 Hz inhibited 35S-sulfate 
incorporation compared to the 15% static group (16%; p<0.002) for MPCs grown in 
media containing TGF-β1, but did not alter 35S-sulfate incorporation compared to the 
15% static group for MPCs grown in media lacking TGF-β1.  DNA content was 
comparable between the loading groups for each media formulation (DNA data not 
shown).   
Since loading frequency was found to influence both day 1 BAC and MPC 
biosynthesis, an experiment was conducted with day 7 cultures to determine if sensitivity 
to loading frequency was maintained with additional time in culture.  Oscillatory 
compressive loading modulated radiolabel incorporation rates in both BAC and MPC 
cultures, and the response across the two cell types was markedly different.  However, 
the two frequencies evaluated (1.0 and 0.33 Hz) elicited similar effects for each cell type 
(Figure 20).  In BAC cultures, 3H-proline and 35S-sulfate incorporation were stimulated in 
the 1.0 Hz loading group compared to the 15% static group (3H-proline at 19%; p<0.001; 
35S-sulfate at 10%; p<0.02) and in the 0.33 Hz loading group compared to the 15% static 
group (3H-proline at 16%; p<0.003; 35S-sulfate at 10%; p<0.02).  DNA was also found to 
be inhibited in the 1.0 Hz loading group compared to the 15% static group (7%; p<0.02; 
data not shown).  In MPC cultures, 35S-sulfate incorporation was inhibited in the 1.0 Hz 
loading group compared to the 15% static group (14%; p<0.001) and in the 0.33 Hz 
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loading group compared to the 15% static group (11%; p<0.008), but 3H-proline 
incorporation and DNA content were comparable between the loading groups (DNA data 
not shown).   
Mechanical Testing of MPC-Seeded Alginate Cultures 
Mechanical testing was performed to investigate the behavior of MPC-seeded 
alginate cultures subjected to oscillatory compressive loading, and gels were evaluated at 
days 1 and 7.  As a baseline comparison to other hydrogel culture systems, the dynamic 
compressive modulus of the cell-seeded 2% alginate gels at day 1 was estimated to be 
69kPa.  Hysteresis was observed in the stress-strain curves for the cell-seeded alginate 
gels (Figure 21; data shown at 0.1 Hz), indicating that nonlinear behavior occurred with 
oscillatory loading due to the viscoelastic nature of the alginate. Stress relaxation was 
observed in all samples, with a rapid drop in the peak compressive loads during the first 
~10 minutes of loading, a further drop over the next ~30-60 minutes, and then a more 
gradual decline throughout the remainder of testing (data not shown).   
A primary reason for conducting the mechanical testing was to evaluate whether lift-
off, the loss of contact between the loading platen and the gel face, occurred during 
oscillatory compressive loading.  A notable static offset was incorporated into the 
oscillatory loading protocol to compensate for the viscoelastic nature of the alginate gel 
and to minimize the potential for lift-off.  Traces of position versus time and load versus 
time (Figures 22-23) were compared for assessment of lift-off.  At loading initiation, load 
traces showed compressive loads throughout, indicating that contact was maintained 
between the platen and the gel surface.  It should be noted that the load curves were not 
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completely symmetric.  The peak corresponding to the highest platen position was 
broader than the peak corresponding to lowest platen position.   
After loading for three hours, the load traces showed a zero (or positive) load level 
corresponding to the highest platen position for both the day 1 and day 7 gels, although 
the roughly sinusoidal shape of the load-time curve was maintained.  The minimum 
compressive load was found to become more positive with further time in culture (data 
not shown), suggesting the presence of an artifact in the load cell readings.  The artifact 
could have resulted from incorrect taring of the load cell and/or drift in the load cell 
during testing, although the source of the artifact could not be determined during testing 
of multiple samples over several days.  Therefore, the load values were considered to be 
inaccurate and the gels were likely not experiencing actual zero loads during mechanical 
testing.  Furthermore, given that there was no flattened or linear appearance in the load 
curve corresponding to the region of the highest platen position, the data suggest that 
contact was maintained between the platen and the gel surface.  Overall, mechanical 
testing to replicate the specific protocol used in the oscillatory loading experiments 
indicated that stress relaxation was significant but lift-off was minimal during oscillatory 
loading of MPC-seeded alginate gels at culture days 1 and 7.  Additionally, no major 
differences were noted in the behavior of the alginate gels over the frequency range 
evaluated.         
Discussion 
Orthopaedic tissues such as cartilage and bone experience dynamic and complex 
mechanical stimulation under normal loading.  Mechanical stimulation also plays a role 
in orthopaedic tissue development and repair.  MPCs have been identified as a potential 
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cell source for orthopaedic tissue engineering strategies, which substantiates the need for 
extensive exploration into the mechanoresponsiveness of these cells.  Determining how 
progenitor populations respond to types of loading known to modulate differentiated cells 
is one critical area of investigation.  This work evaluated biosynthesis during continuous 
oscillatory compressive loading of MPC/alginate cultures utilizing a loading protocol 
shown to enhance biosynthesis of articular chondrocytes in hydrogel suspension.         
MPCs supplemented with TGF-β1 to support chondrogenic differentiation were 
demonstrated to alter biosynthesis in a culture time-dependent and frequency-dependent 
manner upon application of oscillatory unconfined compressive loading.  MPCs showed a 
lack of response to 0.1 Hz oscillatory loading at culture days 1 and 4, but were found to 
respond to oscillatory loading in a stimulatory manner for both 35S-sulfate and 3H-proline 
incorporation at culture day 7.  The additional time in culture preceding load initiation 
supported increases in proteoglycan synthesis and sGAG content, indicative of the 
progression of chondrogenic differentiation.  Chondrogenic differentiation could result in 
cellular changes that support transduction of mechanical signals resulting from oscillatory 
compression, such as changes in cytoskeletal components, membrane channels, or cell-
surface proteins.  However, proteoglycan accumulation in the day 7 cultures resulting 
from the extended time preceding loading initiation could also support specific 
interactions between MPCs and extracellular matrix components, such as hyaluronan.  
Human MPCs have been shown to express CD44, the hyaluronan receptor, and CD29, 
the β1 integrin subunit [113].  Integrins have been previously demonstrated to play a role 
in chondrocyte mechanotransduction [206].  The response of the day 7 MPC cultures to 
oscillatory loading could be related in part to these matrix interactions.  Importantly, 
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modulation of biosynthesis in day 7 cultures was demonstrated to depend on the loading 
frequency.  Inhibition of 35S-sulfate incorporation occurred with oscillatory loading at 1.0 
Hz, in contrast to the stimulatory response observed with loading at 0.1 Hz. 
In contrast to our work, a preliminary radiolabel-compression study evaluating human 
adipose-derived adult stem cells in agarose suspension with chondrogenic media 
observed inhibition of biosynthesis with oscillatory loading at 0.1 Hz [207].  In that 
study, continuous cyclic mechanical compression beginning on culture days 4 or 7 
inhibited 3H-proline incorporation and decreased the DNA content of the cultures, while 
day 4 loading also inhibited 35S-sulfate incorporation.  The dissimilar results noted 
between our work and this study, particularly at the day 7 culture time, could be related to 
possible differences between the two cell types or to experimental differences, including 
the gel material (alginate versus agarose) and the load duration (20 hours versus 48 
hours).       
The influence of TGF-β1 supplementation on MPC biosynthesis during oscillatory 
compressive loading was directly assessed by comparing the response of MPC cultures 
supplemented with TGF-β1 to MPC cultures lacking TGF-β1 supplementation for 
loading on day 1.  The results of altering TGF-β1 supplementation clarified that day 1 
MPCs were unresponsive to oscillatory loading at 0.1 Hz whether cultured in the 
presence or absence of TGF-β1.  However, an interesting difference was noted with 
loading at 1.0 Hz.  Cultures grown in media lacking TGF-β1 were insensitive to 
oscillatory compressive loading, in contrast to the inhibitory response demonstrated by 
MPCs grown in media with TGF-β1.  This may indicate that the undifferentiated MPCs 
lack the ability to transduce mechanical signals from oscillatory compressive loading in 
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alginate suspension, while TGF-β1 stimulation could result in rapid cellular changes 
enabling transduction of mechanical signals in the day 1 cultures, albeit transduction 
resulting in inhibition of proteoglycan synthesis.     
While the experiments in this chapter focused on MPC biosynthesis during oscillatory 
compressive loading, it was necessary to evaluate BAC biosynthesis during oscillatory 
loading to help identify appropriate loading parameters given the lack of information 
regarding loading of early BAC/alginate cultures.  It was found that BACs modulated 
proteoglycan and protein synthesis during oscillatory compressive loading at early culture 
times ranging from 1 to 7 days.  Changes in biosynthesis were strongly influenced by 
loading frequency at day 1.  At the lowest frequency evaluated (0.1 Hz), oscillatory 
compressive loading stimulated radiolabel incorporation rates in day 1 cultures, but 
increasing the loading frequency by a single order of magnitude resulted in an inhibition 
of radiolabel incorporation rates.  At day 7, modulation of 3H-proline incorporation was 
independent of loading frequency, while modulation of 35S-sulfate incorporation showed 
a limited dependence on frequency.     
Previous reports on loading of early BAC/agarose cultures have been contradictory 
regarding frequency influences.  Buschmann et al. showed that continuous oscillatory 
compression stimulated 35S-sulfate and 3H-proline incorporation for BACs in agarose 
suspension (day 2-5 cultures) and the response was found to be comparable across 
loading frequencies ranging from 1.0 to 0.01 Hz [24].  Lee and Bader showed that 
continuous oscillatory compression of day 1 BAC/agarose cultures influenced sGAG 
accumulation in a frequency-dependent manner ranging from inhibitory at 0.3 Hz to 
stimulatory at 1.0 Hz to no change at 3.0 Hz, while 3H-proline incorporation was 
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inhibited at all frequencies [62].  Differences in the frequency response between our work 
and these studies could be related in part to differences in the gel material used, with 
agarose being a stiffer material than alginate [15].  Additionally, the duration of 
continuous loading was different across the studies and the compression amplitude used 
in the Lee and Bader study was more than double the amplitude level used in both our 
work and the Buschmann study.  
Comparing changes in biosynthesis upon application of oscillatory loading for the 
MPC and BAC cultures at different frequency levels and different culture times revealed 
some interesting observations.  Changes in proteoglycan synthesis during oscillatory 
compressive loading were similar at 1.0 Hz but different at 0.1 Hz in the two cell types at 
day 1.  Since mammalian cells cannot specifically interact with the surrounding alginate 
[193] and extracellular matrix accumulation would be limited at this early culture time, 
the two cell types were likely subjected to similar changes in the local environment with 
oscillatory compressive loading.  One possible explanation for the different cell responses 
is that distinct signal transduction pathways are being utilized to modulate 35S-sulfate 
incorporation for the two loading frequencies.  The MPCs would appear to have the 
appropriate cellular machinery to respond to the higher frequency signal but not to the 
lower frequency signal, while BACs are responsive to both signals.  It seems quite 
plausible that BACs freshly isolated from tissue and culture-expanded prechondrogenic 
MPCs could have different levels of cytoskeletal organization and membrane-associated 
proteins that might result in distinct signal transducing capabilities.  At day 7, 
proteoglycan synthesis was stimulated in BAC cultures but inhibited in MPC cultures 
with 1.0 Hz oscillatory loading, while proteoglycan synthesis was stimulated in MPC 
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cultures with 0.1 Hz oscillatory loading.  This frequency difference may suggest that the 
mechanisms supporting 35S-sulfate incorporation increases at day 7 are distinct in the two 
cell types.  Interactions between cells and the developing pericellular matrix may be more 
substantial for BACs than MPCs at day 7, for example, given the more rapid sGAG 
accumulation in BAC cultures during the first week of culture.     
Oscillatory unconfined compressive loading of the alginate cultures will produce a 
number of changes in the local environment around the cells which could contribute to 
the modulation of biosynthesis observed in this work, including changes in fluid pressure 
and fluid flow.  With unconfined compression, fluid pressure and fluid flow depend on 
radial position within the gel [208].  Maximum fluid pressure occurs in the center of the 
gel and minimum pressure occurs at the gel periphery.  Conversely, fluid flow velocity is 
minimal in the gel center and highest at the periphery.  The distribution of fluid pressures 
and fluid flow velocities within the gel will depend on loading frequency.  The measured 
peak stress can be used to approximate the peak fluid pressure resulting from oscillatory 
loading [209].  The peak stress resulting from oscillatory loading of the MPC/alginate 
cultures was determined to be <5 kPa by mechanical testing.  Since this peak stress is 
several orders of magnitude lower than the hydrostatic pressures shown to stimulate 
biosynthesis in chondrocyte-seeded agarose gels [210], it seems unlikely that fluid 
pressurization contributed to the loading response in these experiments.  Fluid flow could 
contribute to enhanced transport.  However, a recent modeling study of oscillatory 
unconfined compression in agarose gels found minimal fluid flow in the gel with loading 
[191]. 
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Matrix-independent cell deformation and/or cell-matrix interactions will also be 
present with oscillatory compressive loading, depending on the amount of matrix present 
around the cells.  With unconfined compression of cylindrical gels, there will be 
compressive strains applied along the loading axis and tensile strains applied along the 
radial axis.  It has been demonstrated that gross 20% uniaxial compression of day 1 
chondrocyte/alginate cultures results in cell and nucleus deformation [194].  Stretch-
activated ion channels supporting calcium influx have been identified in chondrocyte 
cultures [65], and membrane stretch associated with cellular deformation could lead to 
channel activation.  However, the production of a local pericellular matrix may notably 
alter the degree of deformation experienced by cells in hydrogels subjected to 
compression.  One study found that the extracellular matrix produced in culture after 3-6 
days protected isolated BACs in agarose from deforming under gross 20% compressive 
strain [197].  It is not known if the degree of matrix accumulation in the alginate gels at 
day 7 would reduce compression-induced deformation of either BAC or MPC cultures 
similar to that observed in agarose cultures.  The loading frequency differences observed 
in these experiments could result from a strain rate-dependent signaling mechanism, 
which could potentially be mediated by cell deformation or cell-matrix interactions.   
Very limited knowledge is available regarding mechanisms responsible for the 
modulation of 35S-sulfate and 3H-proline incorporation during compressive loading of 
cartilage explants or isolated chondrocytes.  Uniaxial compression of BAC/agarose 
cultures and fluid flow over chondrocyte monolayers have both been shown to increase 
intracellular calcium and may involve calcium influx through various types of ion 
channels [211, 212].  Intracellular calcium is involved in many signaling pathways, 
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although direct links to proteoglycan and protein synthesis appear to be lacking.  
Lowering the pH of the local environment around chondrocytes, such as occurs with 
static compression of cartilage explants, has been directly linked to inhibition of 
biosynthetic rates [213].  However, this mechanism would not be present in oscillatory 
compressive loading of cell-seeded gels at amplitudes in the range of 3%.  In a much 
different system without loading influences, protein synthesis was shown to be sensitive 
to intracellular potassium levels in oocytes [214].  If this observation could be applied 
broadly to intracellular ion levels, it would suggest a mechanism for protein synthesis 
modulation applicable to compressive loading of chondrocytes and MPCs.  While loading 
influences on chondrocyte biosynthesis have been described for many different types of 
loading and cell culture formats, much remains to be learned about the underlying 
transduction events supporting these changes.   
In conclusion, this work has demonstrated that MPC cultures undergoing 
chondrogenic differentiation respond to oscillatory unconfined compressive loading in a 
culture time-dependent manner.  For a loading protocol that stimulated biosynthesis in 
chondrocyte cultures, oscillatory loading stimulated proteoglycan and protein synthesis in 
day 7 MPC cultures, but the stimulatory response did not occur in earlier MPC cultures.  
For both MPC and BAC cultures, complex interactions were observed between culture 
time, loading frequency, and the modulation of biosynthesis, which may reflect inherent 
































Figure 17: Dynamic Loading System for Radiolabel-Compression Experiments. 
Top: Compression device (i.e. dynamic loading system) used to apply controlled 
deformation to gels situated within the bioreactor cassette via stainless steel platens 
located on the bottom surface of the bioreactor lid. The bioreactor lid is mounted to the 
upper plate of the loading frame, and this upper plate is bracketed to the front face of a 
linear table. Bottom: Close view of bioreactor cassettes attached to the loading frame.  
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Table 7: Summary of Studies Evaluating MPC and BAC Biosynthesis During 
Oscillitory Loading. For studies 2 and 3, media supplementation (± TGF-β1) was a 
secondary experimental variable that was evaluated for day 1 MPC cultures.  
 
 Experimental Variable 
(Experimental Constant) 
Levels Evaluated Cell Type 
Study 1 Loading Frequency 
(Day 1 Loading) 
1.0, 0.33, 
or 0.1 Hz 
BAC 
 
Study 2 Loading Day 
(0.1 Hz Loading Frequency) 
Day 1, Day 4, 
or Day 7 
MPC & BAC 
Study 3 Loading Frequency 
(Day 1 & Day 7 Loading) 
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Figure 18: Loading Frequency Comparison for Oscillatory Compressive Loading of 
BAC/Alginate Day 1 Cultures. Biosynthesis during loading was evaluated in 
dynamically loaded gels (15 ± 3% compression) for oscillatory frequencies of 1.0 Hz, 
0.33 Hz, or 0.1 Hz and was compared to biosynthesis in control gels held at 15% static 
compression. For each loading frequency evaluated, the dynamically loaded data was 
normalized to its paired 15% static data. Values are mean ± SEM (n=8 gels/loading 
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Figure 19: Cell Type and Culture Time Effects on Mechanoresponsiveness.  
Biosynthesis during oscillatory compressive loading was evaluated on days 1, 4, and 7 in 
both BAC and MPC cultures. MPCs were grown in chondrogenic media (media with 
ITS+ and TGF-β1) and BACs were grown in media with 10% FBS. Dynamically loaded 
gels (15 ± 3% compression; 0.1 Hz) were compared to control gels held at 15% static 
compression. Each dynamically loaded data set was normalized to the paired 15% static 
data set. Values are mean ± SEM (n=7-8 gels/loading group/experiment; 2 experiments).  








Table 8: Effects of TGF-β1 Supplementation on Biosynthesis during Loading for 
Day 1 MPC Cultures. Starting on Day 0, MPC gels were cultured in the absence of 
TGF-β1 (-TGF-β1) or were supplemented with TGF-β1 at 10ng/ml throughout (+TGF-
β1). Dynamically loaded gels (15 ± 3% compression; 0.1 Hz) were compared to control 
gels held at 15% static compression for loading on culture day 1. Values are mean ± SEM 












Dynamic 1.036 ± 0.036 1.049 ± 0.035 




Dynamic 0.931 ± 0.033 0.949 ± 0.028 






Table 9: Biosynthesis and Matrix Accumulation for BAC and MPC Cultures. MPCs 
were grown in chondrogenic media (media with ITS+ and TGF-β1) and BACs were 
grown in media with 10% FBS. Cultures were grown to days 1, 4, and 7. Samples are 
from the 15% static compression group of the second loading experiment shown in 
Figure 19 (mean±SEM; n=8gels/day/cell type). * denotes significantly different versus 
Day 1 for the designated cell type. ‡ denotes significantly different versus Day 4 for the 













Day 1   1.06 ± 0.04   0.032 ± 0.001  0.229 ± 0.005 
Day 4 * 5.21 ± 0.15 * 0.169 ± 0.006 * 0.320 ± 0.008 
Day 7    *‡ 19.66 ± 0.69 *‡ 0.322 ± 0.009 *‡ 0.348 ± 0.008 
 
BAC 
   
Day 1    6.76 ± 0.34    0.202 ± 0.009      0.161 ± 0.008 
Day 4 * 24.96 ± 0.59 *  0.350 ± 0.014   *  0.200 ± 0.008 
Day 7    *‡ 37.32 ± 0.99 *‡ 0.284 ± 0.010   *  0.204 ± 0.006 
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Table 10: Effects of TGF-β1 Supplementation on Biosynthesis during Loading for 
Day 1 MPC Cultures Loaded at Higher Frequencies. Starting on Day 0, MPC gels 
were cultured in the absence of TGF-β1 (-TGF-β1) or were supplemented with TGF-β1 
at 10ng/ml throughout (+TGF-β1). Dynamically loaded gels subjected to 15 ± 3% 
compression at frequencies of 1.00 Hz or 0.33 Hz were compared to control gels held at 
15% static compression for loading on culture day 1. Values are mean ± SEM (n=8 












Dynamic 1.00Hz   *0.836 ± 0.014 0.983 ± 0.018 
Dynamic 0.33Hz    0.903 ± 0.017 0.980 ± 0.024 




Dynamic 1.00Hz 1.053 ± 0.048   1.118 ± 0.031 
Dynamic 0.33Hz 1.050 ± 0.040   1.116 ± 0.027 









































































Figure 20: Evaluation of Biosynthesis during Loading for Day 7 Cultures at Higher 
Loading Frequencies. Dynamically loaded gels subjected to 15 ± 3% compression at 
frequencies of 1.00 Hz or 0.33 Hz were compared to control gels held at 15% static 
compression for both BAC and MPC cultures. BACs were grown in media with 10% 
FBS, while MPCs were grown in chondrogenic media with ITS+ and TGF-β1. Values are 
mean ± standard error and have been normalized to the 15% static control level (n=8 















































Figure 21: Stress-Strain Curve for Oscillatory Compressive Loading at 0.1 Hz. The 










































































































































Figure 22: Comparing Load and Position Waveforms for Day 1 Gels. Oscillatory 
compressive loading was conducted at 1.0 Hz (top) and 0.1 Hz (bottom). Waveforms for 
three loading cycles are shown corresponding to loading initiation (i.e. 0 hours) and to 




































































































































Figure 23: Comparing Load and Position Waveforms for Day 7 Gels. Oscillatory 
compressive loading was conducted at 1.0 Hz (top) and 0.1 Hz (bottom). Waveforms for 
three loading cycles are shown corresponding to loading initiation (i.e. 0 hours) and to 
loading 3 hours after initiation. 
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CHAPTER 6 
CONCLUSIONS AND RECOMMENDATIONS 
 
Conclusions 
Bone marrow-derived mesenchymal progenitor cells (MPCs) hold much promise as 
an alternative cell source for cartilage tissue engineering and other cell-based cartilage 
repair approaches.  While previous studies have established that MPCs from humans and 
a number of other species undergo in vitro chondrogenic differentiation, additional 
research is needed to define conditions that will enhance chondrogenic differentiation of 
MPCs, increase matrix production by differentiating cultures, and support development 
of functional tissue-engineered cartilage constructs.  Mechanical loading may be an 
important factor in the initiation and development of chondrogenic MPC cultures.  
However, studies concerning the specific effects of mechanical stimulation on MPCs 
seeded within 3-D matrices have been limited.  This thesis work evaluated the influence 
of dynamic mechanical stimulation on in vitro chondrogenic activity and biosynthesis of 
differentiating MPCs within hydrogel suspension.   
In preparation for the loading experiments, media supplements were evaluated for 
promoting chondrogenic differentiation of goat MPC/alginate cultures.  The conclusion 
of this preparatory work is that TGF-β1 is a potent supplement for stimulating 
chondrogenic differentiation in goat MPC/alginate cultures.  Importantly, the 
chondrogenic response to TGF-β1 is notably enhanced by the exclusion of Dex, a factor 
used routinely with MPCs from other species.  TGF-β1 supports the appearance of 
cartilage matrix components during the first week of culture.  Furthermore, distinct MPC 
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cultures can be identified between culture days 1 and 7 based upon proteoglycan 
synthesis and matrix accumulation levels. 
A primary conclusion of the thesis work is that oscillatory unconfined compressive 
loading of goat MPC/alginate cultures in chondrogenic media does not enhance the 
chondrogenic activity of differentiating MPCs above the level supported by chondrogenic 
media alone for loading applied 3 hours/day for three to six consecutive days.  
Furthermore, the length of the preculture period preceding loading initiation, ranging 
from one to seven days, does not influence the lack of effect for oscillatory loading.  
These conclusions have implications for the future design of mechanical preconditioning 
strategies to support development of cartilage constructs using MPCs.   
Another primary conclusion of the thesis work is that the mechanoresponsiveness of 
goat MPC/alginate cultures to oscillatory unconfined compressive loading is culture time-
dependent for a loading protocol shown to stimulate biosynthesis in chondrocyte cultures.  
Following seven days in culture with chondrogenic supplements, MPCs exhibit 
stimulation of proteoglycan and protein synthesis with oscillatory loading, while the 
stimulatory response is absent in MPCs at earlier culture times.  These results help to 
further characterize the phenotype of differentiating MPC cultures. 
A secondary conclusion of the thesis work is that the stimulation of biosynthesis 
during oscillatory unconfined compressive loading is dependent on the loading 
frequency.  This conclusion is restricted to chondrogenic cultures with limited matrix 
accumulation, such as day 7 differentiating MPC cultures and day 1 BAC cultures.  
Stimulation of biosynthesis in chondrocyte cultures having more extensive matrix 
accumulation is relatively insensitive to loading frequency.  The complex interactions 
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observed between culture time, loading frequency, and the modulation of biosynthesis 
may reflect inherent characteristics of the alginate culture system used in this work. 
Comparing the two primary conclusions of the thesis work indicates differences in the 
MPC response to oscillatory unconfined compressive loading.  The stimulation of 
biosynthesis during dynamic loading observed in day 7 MPC cultures, described in 
chapter 5, contrasts to the lack of modulation of chondrogenic activity following dynamic 
loading observed for all culture times, described in chapter 4.  This difference in results 
may suggest underlying differences in the ability of MPCs to translate mechanical signals 
into cellular responses.  The mechanotransduction pathways that would support 
enhancement in 3H-proline and 35S-sulfate incorporation during 20 hours of loading could 
be distinct from mechanotransduction pathways that would support sustained changes in 
chondrogenic activity, which would likely involve changes in gene expression leading to 
further changes in matrix synthesis and accumulation.  However, the difference in results 
could also indicate that differences in the loading protocols influenced the ability of the 
MPCs to respond to the applied oscillatory compressive loading.  The stimulation of 
biosynthesis was observed only at a loading frequency of 0.1 Hz, but the chondrogenic 
activity experiments were conducted at a loading frequency of 1.0 Hz.  Also, the 
stimulation of biosynthesis occurred in response to 20 hours of continuous loading, while 
the chondrogenic activity experiments typically evaluated the response to a total of 9 
hours of loading applied over three days.  An additional consideration for the difference 
in results concerns how changes in biosynthesis are translated into detectable changes in 
matrix accumulation, which could be influenced by multiple timing issues including the 
duration of the loading period and the number of days or bouts of loading applied.     
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The conclusions for oscillatory compressive mechanical loading effects on MPC 
chondrogenic activity and biosynthesis are defined by and specific to the 3-D matrix in 
which the MPCs are cultured.  This thesis work describes loading influences for 
suspended MPCs initially cultured in isolation of specific interactions with the 
surrounding alginate gel material, as the alginate chains are lacking appropriate adhesion 
sequences.  However, these specific interactions could be potentially important mediators 
of mechanotransduction in cultures where extracellular matrix accumulation is limited.  
Further work is needed to more broadly understand how oscillatory compressive loading 
may influence MPC chondrogenic activity and biosynthesis.   
Recommendations 
The experiences with MPC expansion and differentiation have suggested a general 
recommendation for studies with MPCs, in addition to the specific suggestions noted 
below.  In this thesis work and throughout the literature, MPCs are currently used with 
very little characterization of the initial population.  Assessment of cell-surface marker 
expression, which has been used previously to a limited degree, would be one possible 
method for population characterization [132-134].  Using cell-surface markers to initially 
characterize donors and to monitor possible changes associated with in vitro expansion 
could provide insight regarding donor variability and passaging effects, issues noted in 
the literature to be relevant for multiple MPC species [123, 215, 216].  MPC 
characterization would also strengthen comparisons between studies by different 
investigators.   
The evaluation of goat MPC chondrogenic differentiation and subsequent matrix 
accumulation in response to chemical stimulation would be strengthened by further 
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exploration of Dex effects.  In particular, an experiment evaluating Dex concentration 
would provide valuable information.  Since a comparison of the goat results to those in 
previous studies with human MPCs indicated that the response to Dex could be species-
specific, it would be interesting to conduct experiments comparing chondrogenic 
differentiation of goat and human MPC donors.  Additionally, while experiments in this 
thesis focused on differentiating MPC cultures, future work could focus on the long-term 
development of tissue-engineered implants using MPCs.  The culture media currently 
used to support differentiation may not be ideal for extended in vitro growth of the MPC 
cultures.  Identifying growth factors other than TGF-β1 or determining when serum could 
be included in the culture media are possible suggestions for enhancing the culture media.  
Use of bioreactors with MPC cultures will be another important consideration for long-
term in vitro tissue development.                        
For the evaluation of mechanical loading influences on MPC chondrogenic activity, 
the effects of hydrogel and chondrogenic supplementation are issues which need further 
clarification.  Conducting experiments with MPCs cultured in hydrogels containing cell-
adhesion sequences would enable assessment of loading effects in an environment more 
representative of the in vivo situation.  Modulating the TGF-β1 dose used to culture the 
MPCs might enable a more sensitive assessment of the relative influences of chemical 
and mechanical signals on the chondrogenic activity of differentiating cultures.  As the 
loading frequency was shown to be important for changes in MPC biosynthesis in 
response to loading, evaluating loading influences at lower frequencies should be 
investigated.  Additionally, the biochemical analyses utilized in the experiments on 
chondrogenic activity provided a lumped population response.  Having an assay to assess 
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the response of individual cells would enable a more thorough evaluation of loading 
responses.  One possible approach for future studies would be to evaluate isolated MPCs 
after loading with fluorescence activated cell sorting in combination with antibodies for 
cartilage matrix markers, with cell isolation achieved by dissolution of the MPC/alginate 
gels with calcium chelators.   
In evaluating the mechanoresponsiveness of the MPCs as related to biosynthesis, 
timing effects associated with progression of chondrogenic differentiation are one area 
for additional exploration with the current culture system.  It would be interesting to 
evaluate loading influences at culture times beyond day 7, in part to determine whether 
loading at higher frequencies is capable of stimulating biosynthesis in the MPCs cultures 
similar to the response observed in the BAC cultures at day 7.  To clarify factors 
contributing to the response of the day 7 MPC cultures, an experiment could be 
conducted in which standard day 7 cultures are compared to modified day 7 cultures 
lacking matrix accumulation.  To modify the day 7 cultures, MPCs could be isolated from 
alginate suspension, subjected to a mild collagenase digestion, and then reintroduced into 
alginate suspension.  The influence of the hydrogel composition on the response to 
loading is another issue for further investigation.  Comparing the response of the early 
MPC cultures in hydrogels with and without cell adhesion sequences would be useful.    
In summary, this thesis work has provided an assessment of dynamic mechanical 
loading influences on MPC cultures undergoing chondrogenic differentiation.  The 
results of this work provide an experimental foundation for studying oscillatory 
compressive mechanical loading effects on MPC/hydrogel cultures and have identified 
important experimental variables for further consideration.  The information gained 
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through in vitro studies of differentiating MPC cultures will be important for increasing 
basic understanding of MPCs and may also prove valuable in guiding the future 





GROWTH FACTOR EFFECTS ON CHONDROGENIC DIFFERENTIATION OF 
CANINE MESENCHYMAL PROGENITOR CELLS 
 
While canine MPCs had been demonstrated to undergo in vivo osteochondrogenesis 
and in vitro osteogenesis [109], no reports had described in vitro chondrogenesis in these 
cells.  This work characterized the ability of canine MPCs to undergo in vitro 
chondrogenic differentiation in response to growth factor supplementation during cell 
expansion and subsequent 3-D culture.  FGF-2 was identified as a potent monolayer 
expansion factor influencing 3-D chondrogenic differentiation.   
Methods 
Materials 
Calf thymus DNA was from Invitrogen Life Technologies, Chicago, IL.  Hoechst 33258 
dye, safranin-O, and fast green FCF were from Sigma-Aldrich, St. Louis, MO.  
Hyaluronidase was from Calbiochem, EMD Biosciences, San Diego, CA.  For all other 
items not listed previously, the materials list in the Chapter 3 methods section details the 
vendors for these items and will not be repeated here in the interest of brevity.   
Canine MPC Culture 
Iliac crest bone marrow aspirates were obtained from six canine donors, processed by 
Percoll separation, and plated for adherent primary culture in collaboration with Osiris 
Therapeutics, Inc. [109].  Following primary culture, the cells were expanded for one 
(P1) or two (P2) consecutive passages (8000cells/cm2) in low glucose DMEM containing 
10% FBS and 1% antibiotic/antimycotic.  In selected experiments, 1ng/ml FGF-2 was 
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included in the expansion media.  A pellet culture system was utilized to promote 
chondrogenic differentiation of canine MPCs, based upon its previous use in 
differentiation studies with human and rabbit MPCs [11, 12, 153].  To initiate pellet 
cultures for 3D differentiation experiments, passaged MPCs were suspended in the 
appropriate chondrogenic media, 0.25x106cells (0.5 ml cells at 0.5x106cells/ml) were 
transferred to a 15 ml polypropylene conical tube, and the tubes wers centrifuged for 5 
minutes at ~500-600g to yield a cell layer on the tube base. Within ~24 hours of culture, 
the cell layer detached from the tube base and contracted into a more rounded “pellet” 
shape.  The base chondrogenic media was high glucose DMEM containing 1% ITS+ 
premix, 1% antibiotic-antimycotic, 0.1mM non-essential amino acids, 40μg/ml L-proline, 
and 50μg/ml ascorbic acid-2-phosphate.  Chondrogenic supplements evaluated were 
100nM Dex and 10ng/ml TGF-β1.  All cultures received fresh media changes every 2 
days.   
Experimental Design  
The initial study to validate chondrogenic differentiation in canine MPC donors was 
divided into two separate experiments with three donors evaluated in each experiment.  
Both passage 1 and passage 2 cells were cultured as pellets.  Pellets were cultured to 14 
days in media supplemented with Dex alone or in combination with TGF-β1.  Given the 
noted passage-dependency of chondrogenic differentiation for the positive donors 
identified in the first study, a second study was conducted to evaluate FGF-2 effects on 
MPC passaging and the subsequent chondrogenic differentiation potential.  The second 
study consisted of one experiment with three donors evaluated.  During monolayer 
expansion, MPCs were cultured in standard media or in media supplemented with FGF-2 
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for two passages.  Both passage 1 and passage 2 cells were cultured as pellets.  Pellets 
were cultured to day 14 in media supplemented with Dex alone or in combination with 
TGF-β1.  At the designated harvest time, cultures were taken for biochemical analyses 
(n=3 per condition per donor) or for histological processing (n=2-3 per condition per 
donor) for each of the canine MPC studies.      
Biochemical Analyses 
All samples were rinsed in PBS, weighed, dried in a SpeedVac, and reweighed.  Pellets 
were suspended in 100mM ammonium acetate pH 7.0 containing proteinase K 
(12.5μg/pellet) and incubated overnight at 60ºC.  The digestion solution was analyzed for 
DNA and sulfated glycosaminglycan (sGAG) content.  DNA content was determined 
using Hoechst 33258 dye and quantified against a calf thymus DNA standard [217].  
200μl dye (0.5μg/ml dye in 10mM Tris-HCl, 1mM Na2EDTA, 100mM NaCl pH 7.4 
buffer) was added to 10 μl sample in a 96 well plate.  The mixture was incubated for ~15 
minutes and then measured on a Perkin-Elmer HTS 7000plus plate reader (365nm 
excitation and 465nm emission).  sGAG content was determined using DMMB dye and 
quantified against a chondroitin-4-sulfate standard from bovine cartilage [218].  Sample 
dilutions were prepared as necessary in the appropriate base digest buffer.  200μl dye 
(~16mg/ml dye in 41mM NaCl, 40mM glycine pH 3.0) was added to 20μl sample 
dilution in a 96 well plate and then measured immediately at 525nm on a Bio-Tek 
PowerWave X340 plate reader.   
Histological Analyses 
Intact pellets were rinsed in PBS, transferred to 10% neutral-buffered formalin for ~48 
hours, rinsed in PBS, and then stored in 70% alcohol.  Samples were subsequently 
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embedded in paraffin and sectioned at five microns for analysis.  Histological analyses 
were performed using a standard Hematoxylin & Eosin stain and a safranin-O stain, 
which binds to sGAGs (see Appendix B for safranin-O protocol).  An 
immunohistochemical assay was performed (see Appendix B for protocol) with a 
monoclonal antibody provided by the Developmental Studies Hybridoma Bank for Type 
II collagen (IgG II-II6B3).   
Statistical Analysis 
Data were analyzed using ANOVA (significance at p<0.05). 
Results and Discussion 
Initial canine donor validation experiments were conducted in high-density pellet 
culture.  Six donors were evaluated at two expansion levels (passage one and passage 
two).  For cultures supplemented with Dex and TGF-β1, three of six MPC donors (donors 
A02, WN8, and WN9) underwent chondrogenic differentiation in P1 cultures, while only 
donor WN9 underwent differentiation in P2 cultures (Figure 24).  In contrast, 
supplementation with Dex alone did not support differentiation in any donor at either 
passage level.  Chondrogenic differentiation was evidenced by elevated per cell sGAG 
accumulation, by positive safranin-O staining, and by positive type II collagen expression 
(Figure 25).  A portion of Dex only cultures, as well as some Dex and TGF-β1 cultures 
which were lacking safranin-O staining, exhibited a faint positive staining for Type II 
collagen (not shown).   
To further evaluate passaging effects on chondrogenic differentiation, monolayer 
expansion of MPCs in the presence of FGF-2 followed by pellet culture with Dex and 
TGF-β1 supplementation was evaluated in three donors.  It was found that FGF-2 
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significantly enhanced differentiation in both P1 and P2 cultures supplemented with Dex 
and TGF-β1.  Comparing cultures expanded with FGF-2 to control cultures, sGAG/DNA 
was significantly higher (p<0.005) and safranin-O positive matrix was more extensive for 
all groups expanded with FGF-2 except donor WN8 at passage 1 (Figure 26).  In fact, 
passaging with FGF-2 promoted differentiation in donor A01, a donor which had failed 
previously to undergo differentiation at any passage.  Pellets containing media 
supplemented with Dex only were also cultured and no chondrogenic differentiation was 
observed for either of the expansion conditions (data not shown).   
This work identified FGF-2 as a potent monolayer expansion factor influencing 
subsequent 3-D chondrogenic differentiation.  Canine MPC expansion with FGF-2 
enhanced chondrogenic differentiation and matrix accumulation, similar to FGF-2 
influences on human and rabbit MPCs [123, 219].  The extension of chondrogenic 
capacity to later passages noted in canine MPCs is also consistent with previous data for 
rabbit MPCs [123].  The interaction between FGF-2 and passaging indicates that more 
cells are able to undergo chondrogenic differentiation with exposure to FGF-2 than in 
control media.  FGF-2 may modulate the MPC population as a whole or may selectively 
influence a subset of the proliferating population.  FGF-2 could promote dividing MPCs 
to maintain an undifferentiated state to a greater extent than in control cultures.  
Alternatively, a subset of cells that are undifferentiated in the initial population could 
undergo enhanced proliferation in response to FGF-2, thereby increasing their progeny 
relative to the population as a whole.   
Canine MPC chondrogenic differentiation was found to be both donor- and passage-
dependent. The donor variability observed in this study could reflect underlying 
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differences in the cell population present in different donors, but could also indicate 
variability introduced by the MPC harvesting technique. Previous work with canine 
MPCs observed passage dependency during in vitro osteogenesis, and this loss of in vitro 
differentiation with passaging appears to be accelerated in canine MPC populations 
compared to other species [12, 109].  The demonstration of notable donor variability in 
the canine MPCs led to the conclusion that these cells were not an appropriate choice for 
the thesis work.  However, the canine MPC work identified FGF-2 as a beneficial 
monolayer expansion factor influencing 3-D chondrogenic differentiation, and FGF-2 




























































Figure 24: Canine MPC Donor Comparison of Day 14 sGAG/DNA Content. Pellets 
cultures were evaluated for 6 donors (i.e. donor A01) at passage 1 (P1) and passage 2 
(P2). Pellets were grown in media supplemented with Dex only or with both Dex and 
























Figure 25: Histological Analyses of Day 14 Canine MPC Pellets. Cultures were 
supplemented with Dex & TGF-β1. Safranin-O staining (10X, red coloration indicates 
presence of sGAGs) is shown on top and Type II collagen immunostaining (10X, red 
coloration indicates presence of antigen) is shown on bottom. Images are shown for 
donor WN9. 























































Figure 26: Chondrogenic Differentiation in Response to FGF-2 Supplementation 
during Monolayer Expansion. All pellet cultures received Dex and TGF-β1. Top: 
Comparison of day 14 sGAG/DNA content. Bars represent mean ± standard deviation 
(n=3pellets/donor). * denotes significantly different versus control expansion for the 
designated donor/passage. Bottom: Safranin-O staining (10X, red coloration indicates 
presence of sGAGs) of P1 and P2 day 14 cultures for donor A02. 
  


















 IMMUNOHISTOCHEMICAL AND HISTOLOGICAL PROTOCOLS 
 
I. Immunohistochemistry for Type II Collagen Staining 
1.   For paraffin sections (≤ 5micron thickness), follow standard deparaffinization 
      procedure to water. 
2.   Rinse 5 minutes in 1X PBS. 
3.   Apply pepsin solution to tissue sections and incubate 10 minutes, then repeat with 
      fresh pepsin solution.  
4.   Rinse 5 minutes in 1X PBS and repeat rinse. 
5.   Cover tissue sections with 1% gelatin/PBS for 20 minutes. 
6.   Apply diluted (1:4 in 1%BSA/1X PBS) primary antibody (IgG II-II6B3, Develop- 
      mental Studies Hybridoma Bank) to tissue sections and incubate 1 hour. 
7.   Tap off excess antibody, rinse 5 minutes in 1X PBS, and repeat rinse. 
8.   Apply diluted (1:400 in 1%BSA/1X PBS additionally containing 2% serum) 
      secondary antibody (Anti-Mouse IgG, Vector Labs #BA-2001) to tissue sections and  
      incubate 30 minutes. 
9.   Prepare ABC solution by adding 1 drop each of reagent A and B (Vector Labs 
      #AK-5000) to 5ml 1XPBS and let sit 30 minutes. 
10. Tap off excess antibody, rinse 5 minutes in 1X PBS, and repeat rinse. 
11. Apply ABC solution to tissue sections and incubate 1 hour. 
12. Rinse 5 minutes in 1X PBS and repeat rinse. 
13. Rinse 5 minutes in 100mM Tris pH 8.2.  
14. Immediately before using prepare vector red substrate in container wrapped in 
      aluminum foil: To 5ml 100mM Tris pH 8.2 add 1 drop levamisole (Vector Labs #SP- 
      5000) and 2 drops each reagents 1, 2, & 3 (Vector Labs #SK-5100) and mix by 
      inversion. 
15. Apply substrate to tissue sections and incubate up to 45 minutes in dark, checking 
      periodically for color development.  
16. Rinse 5 minutes in tap water and repeat rinse. 
17. Counterstain slides with hematoxylin as per standard procedure. 
 
II. Safranin-O/Fast Green/Weigert’s Iron Hematoxylin Stain 
1.   For paraffin sections (≤ 5micron thickness), deparaffinize to water: Xylene for 3 
      minutes and repeat two times; 100% Alcohol for 2 minutes and repeat two times; 
      95% Alcohol for 2 minutes; water rinse  
2.   Deionized water for 1 minute 
3.   Weigert’s Iron Hematoxylin Working Solution for 1-2 minutes (prepared by 
      combining equal volumes of Part A and Part B solutions and then filtering using 
      Whatman filter paper; Sigma #HT10-79) 
4.   Running tap water rinse for 2 minutes 
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5.   One dip in 1% acid alcohol (1 volume 12N HCl in 99 volumes 70% Alcohol) 
6.   Running tap water rinse for 2 minutes 
7.   0.02% Fast Green Solution for 1 minute (prepared by adding 0.02 grams Fast Green 
      FCF powder, Sigma Catalog #F7258, to 100 mls deionized water) 
8.   1% acetic acid for 3 seconds 
9.   6% Safranin-O solution (Sigma #HT90-4-32) for 5 minutes 
10. Dehydrate slides then coverslip: 95% Alcohol for 1 minute; 100% Alcohol for 10 
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